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Introduction: Traditionally vestibular function has been assessed using caloric 
irrigations; new methods have failed to reach the same level of accuracy. 
Vestibular nerve dysfunction occurs with ‘acoustic neuroma’	 or	 ‘vestibular	
schwannoma.   Quantitative testing of hearing by audiometry is much more 
widely available than quantitative vestibular testing, although consideration of 
vestibular dysfunction is part of clinical management.  Validation of a new 
method of quantitative vestibular function testing could lead to more 
widespread integration into clinical practice and affect decision making (i.e. 
timing of surgery) 
    
 
Methods: A non-blind observational cohort study was undertaken in 31 
participants. Study endpoints were either one or two separate participant 
measures in March/April 2013 the September/October 13.  All participants 
underwent caloric and head impulse testing with video-oculography, while 10 
underwent audiometric assessment. Repeat testing was performed for 10 
subjects, including additional cognitive.  The primary outcome was vestibular 
function test measures.  
 
 
Results:  Video head impulse was strongly correlated with calorics (p=0.01) and 
showed good sensitivity (80%) and specificity (70%).  Dizziness Handicap 
Inventory showed no correlation with other vestibular function measures.  




Conclusion:  Video head impulse testing is comparable to caloric testing to 
assess vestibular function.  Vestibular lesions may lead to cognitive deficits.  
Further research is needed to better understand the role of video head impulse 
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1. Introduction  
 
This thesis seeks to validate the use of video-oculography recorded head impulse 
testing (vHIT) in comparison to the traditional clinical gold standard of 
bithermal caloric testing (calorics) in quantifying vestibular ocular reflex (VOR) 
function in patients with vestibular schwannoma (VS) participants with 
unilateral vestibular schwannoma.  Vestibular schwannoma frequently present 
with hearing loss and tinnitus and will impair vestibular ocular reflex (VOR) 
function. VideoHIT is quicker to perform and therefore more convenient than 
traditional methods such as calorics. This makes it an attractive alternative for 
measuring VOR function, potentially leading to better identification of vestibular 
dysfunction and improved vestibular management.  The potential clinical utility 
of a quantitative measure of the VOR in VS is to characterize vestibular 
hypofunction, so aiding clinical management.  For example, deteriorating 
vestibular function with a modest increase in VS size may indicate the need for 
intervention.  
 
A secondary aim of this thesis is to investigate the relationship between 
vestibular lesions and cognitive function.  Vestibular dysfunction has been in 
several cases demonstrated to produce spatial memory and cognitive function 
defects in both human and animal models.  This thesis aims to further elucidate 





My hypothesis is that video head impulse testing, as a high velocity measure of 
the VOR, will prove useful for detecting significant vestibular impairment among 
those with both symptomatic and asymptomatic VS.  If validated this test would 
allow for documentation of vestibular dysfunction over time and potentially 
influence clinical management, e.g. timing of surgery, and the need for vestibular 
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rehabilitation following surgery.  
 
1.2 Vestibular Impact 
 
With lifetime prevalence of between 20%-30% dizziness is exceedingly 
common(4). studies from Finland and the United Kingdom estimate prevalence 
to be between 21-29%(5-7).  Even after applying strict diagnostic criteria for 
vertigo, the lifetime prevalence is estimated to be 7.8%(8); though the variability 
of study designs makes comparisons difficult. Nonetheless, dizziness is a 
common problem, which can be a major health burden on populations due to its 
debilitating effects(9, 10), with Neuhauser(8)reporting severe impairment in up 
to 80% of sufferers.  
 
Vestibular dysfunction increases the likelihood of falls, which are an established 
cause of morbidity and mortality in the elderly(11-14). Furthermore, the 
likelihood of vestibular dysfunction increases in diabetes mellitus(4). An 
increasing prevalence of diabetes mellitus may lead to an increased burden of 
morbidity and mortality from falls partially attributable to an underlying 
vestibular component (10, 15-17).  
 
It is important to note vestibular dysfunction refers to any pathology affecting 
the vestibular system; this may or may not be symptomatic.  Dizziness refers to 
any fault in spatial perception and stability; it is not specific and may arise from a 
number of systems.  Vertigo is a subset of dizziness in which the individual 
experiences the sensation of rotation; this is frequently of vestibular origin.  
 
It has been reported that between in 30-50% of traditional vestibular function 
testing methods fail to establish a localizing diagnosis(18), with multiple visits to 
the doctor frequently required before an appropriate diagnosis is made(4).  This 





1.3 Vestibular Schwannoma 
 
Vestibular schwannoma account for approximately 80% of cerebellopontine 
angle tumors (19-21).  Vestibular schwannoma most frequently arises from the 
schwann cell layer of the vestibular portion of the eighth cranial nerve.  As VS 
grow nerve compression causes auditory dysfunction, with less pronounced 
vestibular symptoms(22).  
 
1.4 Vestibular Ocular Reflex  
 
The VOR is a three-neuron pathway that transduces vestibular information to 
produce compensatory eye movement(23).  Vestibular lesions disrupt the 
function of this reflex, leading to oscillopsia, dizziness and vertigo(24). Clinical 
assessment of this reflex can be used to test vestibular system function.       
 
1.5 Vestibular Function Testing  
 
Investigation of vestibular function requires the application of a vestibular 
stimulus and the measurement of the reflexive eye movements. Current tests 
include the head impulse test (HIT), calorics, rotational chair testing (RCT), 
Vestibular Evoked Myogenic Potential Cervical (cVEMP), Vestibular Evoked 
Myogenic Potential Ocular (oVEMP).  The specificity and sensitivity of these tests 
in relation to unilateral and bilateral vestibular dysfunction differs.   Much of the 
current literature supports the use of caloric testing in the assessment of 
unilateral vestibular dysfunction (25).	 	As	such	it	is	considered	the	clinical	“gold	
standard”.    Other measures have not consistently reached the same accuracy as 
calorics.   It is possible that some of these limitations are due to their 
compatibility with the available eye recording equipment.   
 
The induced eye movements are quantified by using recording techniques such as 
electro-oculography (EOG), video-oculography (VOG) or scleral search coil 
recording (SCCR).   Electro-oculography is susceptible to eyelid flutters which 
induce a myogenic signal and electrical noise, this adversely effects the trace of 
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the eye movement.   Until recently, video-oculography equipment was heavy  
causing slippage between the camera and the head during movement.  This 
results in measurement artifacts, especially during head impulse testing.  Newer, 
lighter VOG equipment has reduced these problems, both ease of use and 
portability mean that it is more clinically appropriate. Scleral search coil 
recording is painful and requires topical corneal anesthesia. Video-oculography 
shows comparable accuracy to  SCCR, but there is a paucity of studies showing its 




Vestibular damage has been shown to lead to cognitive deficit and problems with 
spatial memory formation in animals and humans(26, 27).  Given the significant 
links to the hippocampus this is likely to be in the form of spatial memory and 
spatial orientation(28-30).   Better understanding of these mechanisms could 
lead to improved interventions and outcomes following vestibular lesions.  




Using a comparative, observational design this study compares two measures of 
VOR function, vHIT and Calorics.   It then relates the results of these tests to 
broader measures of patient function in vestibular schwannoma; audiometry, 
dizziness handicap inventory, tumour size and cognitive function.  In doing so 
validating the accuracy of vHIT in comparison to calorics in quantifying VOR 






2. Literature Review 
 
This literature review evaluates the clinical utility of each measure of vestibular 
function in relation to VS.  First it describes normal vestibular function, and then 
summarizes different vestibular diseases before examining the utility of different 
testing methods, and their role in clinical decision-making.   
 
Currently, quantitative vestibular function is not routinely performed in VS 
management, as such vestibular function tests contribute little to decisions about 
intervention.   The slow growth of	VS	means	that	a	“wait	and	watch”	approach	is	
becoming increasing popular in clinical management of many VS.  Vestibular tests 
may be used to monitor changing vestibular dysfunction during this time that 
may be associated with increasing tumour size.  
 
2.1 The Vestibular System  
 
2.1.1 Vestibular Anatomy 
 
Located in the temporal bone the vestibular system consists of a membranous 
structure bound by a dense bony case called the otic capsule. These are 
collectively known as the vestibular labyrinth, and described as either the bony 
or the membranous labyrinth (Figure 1).  The outer membrane of the vestibular 
labyrinth is the endostium of the otic capsule and within this there are two fluid 
filled compartments.  The perilymph compartment surrounds the endolymph 
compartment which is enclosed by a membranous sheath and which contains the 
sensory components of the vestibular system.  
 
The membranous labyrinth consists of three semicircular canals (SCCs) and the 
otolith organs, the saccule and utricle.  Each semicircular canal lies at right 
angles to the others and dilates at one end to form the ampulla.   The sensory 
system within the vestibular labyrinth comprises the ampullary apparatus of 
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each semicircular canal and the otolith organs in the saccule and utricle. 
Contained in the ampulla are cristae, sensory epithelium supported by a 
connective tissue network, upon which the cupulae sit. These cupulae attach to 
the roof and lateral walls of the membranous labyrinth forming a closed barrier, 
stereocilia from hair cells on the cristae project into the cupula.  The otolith 
organs consist of maculae made up of hair cells and supporting cells.  Layered on 
top of this is the supracopula network, a mucopolysaccharide gelatinous layer 
embedded with the otoconia, small calcium carbonate crystals.   The sacular 
macula lies on the anterior vertical wall of the saccule, while the utricular macula 
lies in the horizontal plane of the utricle.  
 
Hair cells can be divided into type one inner and type two outer hair cells with 
each surrounded by a chalice of nerve endings (Figure 2). Stereocilia decrease in 
height with increased distance from a central kinocilium.  Movement relative to 































Figure 1 Legend: The vestibular labyrinth consists of the three semicircular 
canals and the otolith organs(1). 
 
Figure 2 Legend: Movement of the stereocilia results in the transduction of signals to the vestibular 
nuclei(2) 
 
Figure 1: The Vestibular Labyrinth  
Figure 2: Vestibular Hair Cells 
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Each organ generates a resting potential.  Rotational movements modulate this 
via the SCCs.  While horizontal or vertical movements modulate this via the 
saccule and utricle.  These changes in signal, along with visual and 
proprioceptive information allows for the coordination of balance.   
 
The external aspect of the membranous labyrinth is bathed in perilymph, with a 
high sodium to potassium ratio. The membranous labyrinth is filled with 
endolymph; this has a high potassium to sodium ratio.  The charge difference 
between the two compartments generates an electrochemical gradient allowing 
for vestibular signaling.  Endolymph is produced by the dark cells of the cristae 
and macule and reabsorbed into the endolymphatic sac via the utricular, sacular 
and endolymphatic ducts.    
 
The labyrinthine artery (internal auditory artery) supplies the vestibular 
labyrinth(31).  This normally arises from the anterior inferior cerebellar artery, 
but may also arise from the basilar artery.   
 
Vestibular hair cells are surrounded by nerve endings.  These are part of bipolar 
nerve	fibres	that	have	cell	bodies	located	in	Scarpa’s	ganglia,	the	latter	situated	
within the superior and inferior divisions of the vestibular nerve.  These afferent 
nerves fibres convey stimuli generated by hair cells of the vestibular nuclei.  
Nerve afferents from the superior canals, the lateral canals and the utricle run 
from Scarpa’s ganglia in the superior vestibular nerve. While nerve afferents 
from the inferior canal and the saccule run in the inferior vestibular nerve 
(Figure 3).  These along with the cochlear nerve make up the vestibular cochlear 
nerve.   This runs through the internal auditory canal, along with the facial nerve 
and nervus intermedius, where it terminates in the vestibular nuclei at the level 
of the pontomedullary junction.    
 
There are four main vestibular nuclei, the superior vestibular nuclei, the lateral 
vestibular nuclei, the medial vestibular nuclei, and the dorsal vestibular nuclei.  
Vestibular connections are varied, with nerve projections from the vestibular 
nuclei running to the cortex via the thalamus, the cerebellum, the spinal cord, 
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and oculomotor nuclei(32). Second order afferents arise in the medial and 
superior vestibular nuclei and run in the median longitudinal fasciculus to the 
abducens, trochlear and the oculomotor nuclei.  The lateral vestibular nuclei 
largely supply fibres to the lateral vestibular spinal tract, while the medial 
vestibulospinal tract is largely supplied by the medial vestibular nuclei.  There 
are some direct connections to the cerebellum, though second order afferents 
primarily arising from the medial and inferior vestibular nuclei to supply the 
cerebellum.   Projections to the cerebrum primarily arise from the superior 
vestibular nuclei and run to the thalamus then to the cerebral cortex.  The 
vestibular area is poorly defined; research suggests it may be adjacent to the 
auditory area or insula (33). The medial and inferior nuclei also give off 
connections to the cerebellum.  These central connections are responsible for the 
integration of balance and the somatic responses seen when balance dysfunction 
occurs.   There is evidence for direct connections between vestibular brainstem 














































Figure 3 Legend:  Innervation of the vestibular organ is by the superior and inferior 
divisions of the vestibular cochlear nerve (SVN and IVN).   The SVN supplies the superior 
canal, lateral canal and the utricle.   The IVN supplies the saccule and posterior canal. 
SC: Superior Canal, LC: Lateral Canal, PC: Posterior Canal, Utc: Utricle, Sac: Saccule 
 
 
Figure Three: Vestibular Nerve Origins  
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2.1.2 Vestibular Physiology 
 
Angular acceleration results in endolymph inertia inducing cupula displacement, 
and consequent movement of the stereocilia relative to the kinocilium. 
Stereocilia are connected to each other and to the kinocilium by tip links 
attached in an axis towards the kinocilium, and directly open mechanically gated 
ion channels. A constant flow of potassium into the kinocilium generates a 
resting potential.     As the cilia move the degree of tension present in the tip 
links moderates the opening of the ion channels, grading the degree of vestibular 
response.  Increased movement causes the ion channels to open further allowing 
an influx of potassium ions from the endolymph depolarizing the cell.  This opens 
voltage gated calcium channels; inflowing calcium binds to vesicles releasing 
glutamate into the intrasynaptic cleft activating the postsynaptic bouton, thereby 
generating a nerve potential.  
 
Movement of the stereocilia towards the kinocilium results in depolarization and 
an excitatory signal.  Movement away from the kinocilium results in 
hyperpolarization and an inhibitory signal as tip links are oriented towards the 
central kinocilium. 
 
 Acting as ‘push-pull’ pairs the paired contralateral SCCs generate information 
about rotational movement (Figure 4).  In the context of the VOR the rate of 
discharge is influenced by the movement of the cupula in relation to the 
kinocilium. Rotational head movements produce opposite direction of cupula 
movement on each side and contrary alterations of discharge rate from the 
opposite paired SCCs.  
 
The maculae act to detect gravitational or movements in the horizontal plane. 
Acceleration along one of these planes results in otoconia inertia and 
displacement of the supracopula network.  This induces a cell depolarization, 




2.1.2.1 Vestibular Ocular Reflex 
 
The VOR is a reflex mechanism that regulates gaze stabilization during 
movement(35). Signals from vestibular afferents are stronger when the head is 
rotated towards their respective side.  Consequently the brain detects side-to-
side differences.  The summed hair cell activity from each vestibular end organ is 
conveyed via the vestibular nerves to the vestibular nuclei from here inter 
neurons pass to the contralateral abducens nuclei and rectus muscles via the 
median longitudinal fasciculus (Figure 4).  Fibers also project from the vestibular 
nuclei to brainstem autonomic centers, via the cortex and vestibulospinal tract.  
This process results in compensatory and contralateral eye movements in 
response to horizontal head rotation stabilizing gaze.  This reflex operates 
physiologically during head movements between one to six hertz. Above this 
frequency visual acuity is lost, while at lower frequencies other mechanisms can 
compensate.   
 
During constant head movement, the neural firing rate in the vestibular nerve 
decays at an exponential time constant of five to six seconds.  Central velocity 
storage mechanisms extend the vestibular time constant out to around 20 
seconds, this is the mechanism underlying post rotatory nystagmus.  Visual input 
increases vestibular dumping, reducing post-rotatory nystagmus(36).  
 
The vestibular ocular reflex is moderated in the cerebellum by the floculus and 
the nodulus (37, 38).   The floculus calibrates the VOR gain. Following a lesion to 
the floculus animals show diminished ability to adapt to disorders that increase 
or decrease VOR gain (39).   The nodulus moderates the duration of VOR 
responses (40). 
 
 Gain, phase shift and asymmetry are all quantifiable measures of the VOR.  The 
VOR gain is the ratio of the angular eye movement over the angular head 
movement, measured either in velocity or in change of angular position.   As 
compensatory eye movements should be of equal magnitude but opposite 
direction to head movements, perfect gain is equal to one.  There is not yet 
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accepted cut-offs of abnormal function due to insufficient data, but young, healthy 
adults have a gain approaching 1.0. 
 
2.1.2.2 Role of Inhibitory Interneurons 
 
The vestibular nuclei are connected by commissural neurons.  Each vestibular 
nucleus receives information from the paired semicircular canals (Figure 5).  
This information is integrated via commissural neurons to produce information 
regarding the orientation of the head in space(41).   
 
The commissural system is reciprocal, and functionally inhibitory(42).  Second 
order inhibitory neurons run directly between the paired vestibular nuclei. 
Inhibitory neurons in the vestibular nuclei also receive excitatory input from the 
other contralateral vestibular nuclei.   Consequently each vestibular nucleus can 


















































Figure 4 Legend:  Vestibular Ocular Reflex 
Arc: Excitation of the left lateral canal by left 
sided rotation results in endolymph inertia 
and resultant cupula displacement.   This 
results in eye movements of equal 
magnitude in the opposite direction. 
 
The response in the right lateral canal is the 
inverse of that depicted above. Solid Lines 
indicates the excitatory signals, Dotted 
indicates the inhibitory signals 
LR: Lateral Rectus, MR: Medial Rectus 
 
Figure 4: Vestibular Ocular Reflex Arc 
 
Figure 5: The Paired Semicircular Canals 
 
Figure 5 Legend: The contralateral lateral 
SCC act as a functional pair, as do the 
contralateral posterior and superior 




2.1.2.3 Vestibular Compensation in Unilateral Vestibular Deafferentation 
 
Vestibular compensation is a complex multifactorial process believed to be 
reliant on both cortical and subcortical processes.  This process includes 
adaptive changes in both synaptic and neuronal pathways (43). Several authors 
have highlighted the impact of unilateral vestibular deafferentation on the ipsi 
and contralateral vestibular nuclei resulting in vestibular ocular defects(44-46).   
The vestibular nuclei roles in modulating efferent and afferent output have lead 
to the investigation of their role in vestibular plasticity.       
 
The work of Precht et al(47) first highlighted the importance of the vestibular 
commissural system on vestibular compensation.  Following unilateral 
vestibular deafferentation (uVD) the ipsilateral deafferented vestibular nuclei is 
known to become “quiet”, while the contralateral vestibular nuclei remains 
either normal or becomes hyper excitable due to decreased inhibition from the 
contralateral	“quiet”	vestibular	nucleus.  The hyper-excitable contralateral nuclei 
can then further inhibit the ipsilateral deafferented nuclei due to decreased 
inhibition	from	the	“quiet	nuclei”.	 It	 is	this	 imbalance in vestibular outputs that 
can lead to functional consequences, such as a disrupted VOR and dizziness.  
Normal vestibular function is restored as inhibitory potentials from the normal 
nuclei are reduced.  This effect was by highlighted by Vibert et al(48)who found 
no change in vestibular potentials 1-2 days post trauma, but decreased 
potentials at days 3-4. When bilateral vestibulectomy was performed decreased 
vestibular firing rates were found bilaterally, but no vestibular signs or 
symptoms were present(49).  
 
This highlights that it is the imbalance of vestibular information between the 
relative nuclei that leads to symptoms.  With time the vertigo associated with 
unilateral hypofunction diminishes because of adaptive changes along with 
central nervous system supplementation.  
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The commissural system may be moderated by the inhibitory neurotransmitter 
gamma-Aminobutyric acid (GABA).   A clear pathway has not been shown but 
changes in GABA and GABA receptor action are seen post deafferentation.  Two 
in vitro studies have shown that following deafferentation the functional 
capacity of GABA-A and GABA-B receptors was down regulated in the ipsilateral 
nuclei (48, 50). It is believed that this is to reduce the response to contralateral 
inhibitory input and expediting vestibular compensation.  Both histamine 
production and stress hormones may have a role to play in the modulation of 
GABA release post uVD(51).  Their role has yet to been clearly outlined. 
 
 
2.2 Vestibular Pathology 
 
2.2.1 Vestibular Schwannoma  
 
2.2.1.1 Presentation and Diagnosis 
 
Vestibular schwannoma are a benign, slow growing tumour of the 
vestibulocochlear nerve.  They comprise around 6% of all intracranial 
neoplasms(52).   Vestibular schwannoma usually present with hearing loss but 
can also cause vestibular hypofunction in the affected nerve, disequilibrium, and 
vertigo.   The compromise of bloody supply and mass affects has been proposed 
as a mechanism of audio-vestibular dysfunction. 
 
Presenting symptoms can include unilateral hearing loss (99%), tinnitus (63%), 
dizziness (40%), facial or trigeminal nerve signs (8%) and lower cranial nerve 
signs (3%)(53).  Magnetic resonance imaging (MRI) is used to make definitive 
diagnosis. The clinical work up normally includes pure tone audiometry, speech 
discrimination testing. Even though a large proportion of VS patients suffer 
significant balance disturbance vestibular function is not routinely monitored as 
part of the clinical workup.    Due to their slow growing nature conservative 
management using the watch and wait strategy has become popular in recent 
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years, with patients undergoing repeated MRI scanning to monitor for 
schwannoma growth.  One study found that that up to 57% of tumours did not 
grow during the study periodand among those that did grow the average rate 
was 1.9mm per year (54).  When there is tumour growth either surgery or 
radiotherapy may be recommended. A number of variables may influence 
treatment choice, for example; age, general health, tumour size and patient 
preference. 
 
2.2.1.2 Aetiology  
 
Currently the aetiology of unilateral VS is unknown.  .  There is conflicting 





It is believed that the inactivation of the Neurofibromatosis type 2 (NF2) gene, 
located on chromosome 22 is involved in the pathogenesis of both sporadic 
unilateral and familial VS (59, 60).  Irving et al demonstrated that inactivation of 
both copies occurred in familial and sporadic VS, suggesting that the NF2 gene 
acts as a tumour suppressor (61).  Welling (62) found NF2 mutations in 66% of 
sporadic VS patients, though only 88% of the coding sequence was screened. 
Additions on chromosome 9p and 17q have been found in some tumour samples 
(63).  This indicates that NF2 mutation may not be the only precipitating factor 
in the development of sporadic VS, while further highlighting the complex 
genetic nature of its pathogenesis 
 
The NF2 gene produces schwannomin, a protein that plays a role in linking 
cytoskeletal components to the plasma membrane(64). It is believed that 
schwannomin has a role in maintaining cytoskeletal organization, with increased 
disorganization seen in VS(62).  In doing so schwannomin may act to limit cell 
motility, thus inhibiting excessive tumour growth(65).  Indeed ga the 
introduction of schwannomin through a viral vector has been shown to decrease 
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in vivo growth of VS cells, with increased apoptosis(66-68).  It is believed that 
this mechanism may be under control of external moderators with the loss of the 
schwannomin protein resulting in the inability to appropriately respond to these 
external growth cues (69).  These studies highlight the importance of the NF2 
gene mutations and schwannomin production in the pathogenesis of vestibular 
schwannoma, and raise the possibility of genetic treatment.      
 
 It has been speculated that erythropoietin (EPO) plays an important role in the 
development of the human central nervous system(70). Using a recombinant 
antibody one study found positive staining for EPO in 93% percent of 
schwannoma cell cytoplasm, and 63% of endothelial cell cytoplasm(71).   Falconi 
(72)  also reported the presence of a fast growing vestibular schwannoma 
requiring surgery in a patient treated with EPO.  Tumour size has been 
correlated with the number of vessels present around the tumour capsule as well 
as the degree of blood extravasation(73). Taken cumulatively these results 




The average age at diagnosis ranges between 59-62 years(74).   The reported 
incidence of vestibular schwannoma has ranged from 0.1/100000 per year to 
2/100,000 per year(74-77).  Histopathological studies in cadaveric temporal 
bones have demonstrated an incidence of 0%-2.7% (78, 79). With the 2.7% rate 
likely to be an overestimation due to selection bias, as this would indicate an 
incidence of around 800/100,000 per year.  In recent years the increased 
prevalence of vestibular schwannoma is largely attributed to the increased 
detection of small intrameatal tumours showing few symptoms by MRI (74).  
This has been mirrored by a significant decrease in the number of large tumours 
diagnosed, with studies showing a decrease in diameter from 35mm in 1979 to 
10mm in 2001(76, 80).  
 
Vestibular schwannoma can be classified as intra or extrameatal.  Growth in 
intrameatal tumours is measured by taking the longest length along the 
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intracannalicular space.   Extracannalicular tumours are measured according to 
the largest extrameatal diameter. With extracannalicular tumours classified as 
small 1-10mm, medium 11-20mm, moderately large, 21-30mm, large 31-40 mm 




Vestibular schwannoma show inconsistent growth rates with some growing 
continuously, others growing and stopping while yet others may grow and 
shrink(74). With Stangerup (76) showing that of the tumours that did grow the 
majority did so within the first five years following diagnosis. A recent 
systematic review found that during a 38 month period 46% of tumours grew 
while 8% regressed(74). Observational studies tracking tumour growth rates 
may be subject selection bias as young people with large tumours, and middle-
aged people with medium size tumours are more likely to undergo surgery, 
producing an overabundance of small tumours in studies (76).  No correlation 
has been found between growth rate, sex and age.  
 
Deterioration of PTA and speech discrimination scores are not correlated with 
increasing tumour growth and hearing is known to deteriorate regardless of 
where tumour growth occurs (82).  This highlights the limitations of pure tone 
audiometry and speech discrimination scoring as a functional monitoring 
procedure (60). 
 
2.2.2 Other Vestibular Disease 
 
2.2.2.1 Benign Positional Paroxysmal Vertigo 
 
Benign paroxysmal positional vertigo (BPPV) is characterised by sudden attacks 
of extreme vertigo lasting less than a minute.  Light-headedness, nausea and 
imbalance may also be experienced.  It commonly presents between the ages of 
50-70 years, with a yearly reported incidence between 10.3/100,000 and 
17.3/100,000 people (83).   The majority of BPPV cases are believed to be 
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idiopathic though some may be caused by trauma. Benign Paroxysmal Positional 
Vertigo is caused by small free-floating particles believed to arise from dislodged 
otoconia, known as canalolithasis.  Over time these particles will accumulate to 
form a critical mass.  Head movement then results in cupula displacement due to 
inertia of these dislodged otoconia particles, the consequence of which is 
inappropriate activation of the vestibular apparatus leading to vertigo.  Due to its 
inferior position and gravity effects the posterior semicircular canal is most 
commonly affected.    
 
Attacks may occur in frequent spells over the course of a week, before repeated 
movement breaks up the canalolithasis.   The diagnosis is made on the basis of 
history and clinical examination, including the Dix Hallpike maneuver.  The 
standard maneuver involves quickly moving the patient from a seated to lying 
position on the examination bed holding the head such that the head is moved in 
the axis of the left or right posterior canal.  A positive Dix Hallpike occurs when  
torsional nystagmus is produced, with a less marked up-beat component 
towards the affected ear, this is reversed on sitting up.   The most cases are self-
limiting and resolve within six months.  Treatment options include vestibular 
habituation exercises and physical therapy such as the Epley manoeuver.  





loss, aural fullness, tinnitus and vertigo not lasting more than 24 hours.  It 
presents primarily between the ages of 40-60 years, with a reported incidence of 
between 15/100,000 and 157/100,000 people per year (84).  Nystagmus may be 
present during attacks, often persisting for several days.  Initially this beats 
towards the affected ear, before reversing and beating towards the unaffected 
ear.  This reversal may repeat, therefore direction of nystagmus cannot be used 
to accurately identify the affected side; it is believed that this may be due flow of 
potassium ions across ruptures in the membranous labyrinth which separates 
the endolymph and perilymph compartments. The current aetiological origin is 
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unknown, with the exact pathophysiology controversial.   Current beliefs hold 
that a key pathological component is the formation of endolymphatic hydrops; 
this may be idiopathic or due to infection, trauma or allergens.  Hydrops can be 
due to overproduction or inadequate removal of endolymph leading to 
distortions of the endolymphatic membrane.  Mechanical disturbance due to 
hydrop expansion can lead to destruction of some parts of the membrane 
resulting in mixing of endo and perilymphatic fluids.  The consequence of this is 
inappropriate excitation and inhibition of the vestibular organs as well as the 
organ of Corti producing patient symptoms. Treatment is varied and decided on 
a patient-to-patient basis.   In very mild cases a low salt diet may be suggested.  
As severity of symptoms increases diuretics or vestibular sedatives such as 
betahistine for acute attacks may be used.  In very severe cases a stent may be 
inserted to decrease intratympanic pressure (85, 86).  In intractable cases 
ablation with an aminoglycoside such as gentamicin or surgery may be indicated.  
 
2.2.2.3 Vestibular Migraine 
 
Vestibular migraine can present with spontaneous positional vertigo, dizziness, 
ataxia, frequently with no relationship to headaches.  Typically attacks last 
minutes to hours (87).   Currently the pathophysiology has not been established. 
Patient monitoring during episodes has suggested that a mixed central 
peripheral cause in the pathogenesis is culpable (88, 89).    Intervention can 
include non-pharmacological methods of control with avoidance of triggers such 
as poor sleep hygiene, reactive foods, and dehydration. In more severe cases a 
prophylactic treatment may be required. This may include a vestibular sedative 
or anti-migraine medication including beta-blockers, calcium channel blockers 
or a tricyclic antidepressant.  
 
2.2.2.4 Vestibular Neuritis  
Vestibular neuritis presents with a severe attack of vertigo developing over 
several hours lasting up to days but easing over a period of several weeks(90). 
This may be coupled with non-specific dizziness and imbalance. The median age 
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of presentation is 41, with an incidence of 3.5/100,000 people per year (91). The 
etiology is unknown, but some cases may be due to latent type 1 herpes simplex 
infection of the vestibular nerve(92, 93). 
Clinical testing normally shows spontaneous peripheral nystagmus, and positive 
head impulse test towards the affected side.  The Romberg test may also be 
positive.   The affected side also frequently shows little response to caloric 
stimulation.   
Treatment is currently focuses on reducing the severity of the vertigo symptoms 
rather than dealing with the underlying cause.  H1 receptor antagonists 
including promethazine, and benzodiazepines including lorazepam are 
frequently used.  Corticosteroids such as prednisone have also been used in an 
effort to reduce inflammation and modify the clinical course.   
2.2.2.5 Bilateral Vestibular Failure  
 
Gentamicin over dosing is the most frequently identified as the cause of bilateral 
vestibular failure.  Meniere’s	disease	can	also	 lead	 to	bilateral	vestibular	 failure	
when both inner ears are affected.  Typical presenting symptoms include 
oscillopsia, and balance disturbance.   The diagnosis is most frequently made on 
the basis of clinical examination and reduced caloric response.  Treatment 
options are limited though vestibular function exercises should be recommended.  
 
2.2.2.6 Non-Vestibular dizziness  
 
A wide variety of non-vestibular dizziness exists, with the distinguishing feature 
often the absence of vertigo.  Indeed non-specific dizziness such as presyncopal 
light-headedness frequently is seen in anemia, hypoglycemia and other 
cardiorespiratory conditions.  Extreme anxiety and panic attacks can also lead to 
dizziness.  While central neurological conditions such as cerebellar disease or 




2.3 Vestibular Testing 
 
2.3.1 Assessment of Ocular Responses  
 
Traditionally clinical assessment of vestibular function has relied on observation 
of eye movements, either using the naked eye, Frenzel Glasses, or by video-
nystagmography. During caloric testing the induced nystagmus is usually easily 
observed by the naked eye without eye recording, but the end point can be 
difficult to define. During head impulse testing overt catch-up saccades are 
sought, however, smaller catch-up saccades may occur during the head impulse 
and these may not be seen.  Consequently, naked eye observation of the VOR has 
low sensitivity and high specificity, although sensitivity can increase with 




Electro-oculography (EOG) utilises the standing corneo-retinal potential to 
quantify eye movements; the cornea carries a positive charge relative to the 
retina, creating a dipole(95).    Recording electrodes are placed at the outer 
canthus of each eye, and an earth electrode is placed on the forehead. Horizontal 
eye movement brings the positive cornea into closer proximity to either the 
temporal or nasal electrode inducing a change in voltage between the electrodes, 
quantifying nystagmus produced by caloric or head impulse stimulation(96, 97). 
Measuring the movement of both eyes improves the signal to noise ratio, 
increasing recording accuracy(98).  Electro-oculography can take place in 
conjunction with video recording to allow for clinician observation of eye 









Video-oculography uses goggle-mounted high sample frequency infrared 
cameras to record eye movements, either through identification of iral 
landmarks, or by pupil contrast(100-102). A rotation vector analysis allows for 
3-dimensional measurement(103). The accuracy of VOG technology has been 
validated in comparison to the gold standard scleral search coil recording(104, 
105).  
 
2.3.4 Scleral Search Coil Recording 
 
Scleral search coil recording is considered the gold standard for laboratory based 
eye movement recording(104, 105).  Metal coils are embedded in annular 
contact	lenses	and	placed	over	the	participant’s	pupil.		The	subject	is	placed	in	a	
magnetic field; eye position is then deduced from the amplitude of the current 
induced in the coil by the magnetic field. Accuracy is excellent, with extremely 
high spatial (<<1o) and temporal resolution (<<1ms) (105).  Movement can be 
also characterised in the horizontal, vertical and torsional plane.  SCCR is rarely 
used in the clinical setting, as it requires a specialized laboratory, and is not well 
tolerated.  The cornea has to be anesthetised and the coils can only remain in 
place for a limited amount of time. 
 
2.3.5 Vestibular Testing Techniques  
 
2.3.5.1 Caloric Testing 
 
Caloric reflex testing with eye movement recording has long been considered the 
clinical gold standard for investigation of vestibular hypofunction. In 1906 
Barany(106) proposed that caloric induced convection currents lead to gravity 
induced endolymph movement and consequent nystagmus. Later studies 
indicate that his conclusions are likely to be accompanied by other factors (107). 
However, temperature induced convection currents are still considered the 
primary underlying physiological event(108).  
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The Fitzgerald and Hallpike bi-thermal caloric test, devised in 1942, which 
employs two water temperatures (30°C and 44°C) is in common clinical use 
today(109).  Prior to their study the procedures employed for this examination 
were variable and many caused patient discomfort.  This included multiple 
irrigations using graded temperatures, at extremes from normal body 
temperature.  Fitzgerald and Hallpike believed that the test needed to be 
practical and able to identify small changes in the reflex mechanisms.  They 
concluded that the stimulus should be small to restrict excitation to the lateral 
canal and chose hot and cold stimuli of close equidistance to body temperature 
so that small differences in the reflex mechanisms could be identified.  Their 
recommended method involves irrigating the external auditory meatus of each 
ear with cold (30 °C) and warm (44 °C) water alternately.  Caloric stimulus is 
equivalent to rotational input of 0.02-0.04 Hz (110, 111).  Normally the 
physiological range of the VOR is between two and six HZ(112). 
 
Initially the duration of the induced nystagmus was timed, this allowed canal 
paresis and directional preponderance to be roughly derived(113). The advent 
of electro-oculography allowed direction and speed of slow phase nystagmus to 
be measured. Jongkees utilized this information to create formulae for canal 
paresis,  and directional preponderance (DP)(114).  
 
The sensitivity of calorics in identifying vestibular hypofunction in unilateral VS 
has ranged from 50-100% depending on tumour size(115). As it is considered 
the	“clinical	gold standard”	studies	assessing	new	vestibular	tests	are	compared	
to calorics.  To date newer testing modalities have failed to consistently achieve 
equivalent accuracy.  
 
Incomplete ear irrigation can produce diminished responses. Calorics may 
induce nausea, vertigo and migraine.  Testing may not be possible on those with 
tympanic membrane perforation, or recent ear surgery. Controlling temperature 
and flow rate requires equipment that may not necessarily be available at the 
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bedside. Order effects with cool and warm irrigation have been raised; however, 
there is no indication that this introduces significant systematic bias (116). 
 
Mono-thermal testing has been shown to have lower sensitivity than bi-thermal 
testing but takes less time and reduces patient discomfort (117-119).  Air caloric 
testing using either moist or dry air is comparable to bi-thermal calorics in 
normal individuals(120);  however, the technology is not widely available and 
data in disease is not yet available.  
 
Calorics can be utilized as a measure of VS progression. Tumour sizes exceeding 
20mm in diameter have been correlated with decreasing labyrinth 
excitability(121).  However, no studies relate this to patient function or quality of 
life measures. This is important as the degree of ‘vestibular compensation’	 and	
functional recovery varies between individuals(44).  
 
2.3.5.2 Examiner Induced Head Impulse Testing 
 
Head impulse testing is an established measure of the high velocity VOR. 
Halmyagi’s	 (122) seminal study showed 100% sensitivity and specificity in 
detecting complete canal paresis in patients following unilateral vestibular 
neurectomy. Examiner driven head rotation to one side induces endolymph 
movement, which deforms the cupula of both lateral semicircular canals.  This 
induces both a contralateral inhibitory and an ipsilateral excitatory response 
along the vestibular nerve to the vestibular nuclei. In patients with a unilateral 
deficit the diminished response from the ipsilateral affected side and saturation 
of the contralateral inhibitory response leads to a failure of the VOR and a catch-
up saccade. Testing with a high frequency, short rotational stimulus ensures no 
overlap with other visuo-vestibular pathways.    
 
Catch-up saccades can be recorded using video-oculography and quantified in 
terms of gain.  The lack of sufficient comparable data precludes definition of 
accepted parameters for abnormal gain.  Small data sets indicate normal gains 
range from 0.74-0.96 in healthy subjects (94, 123, 124).  Gains fall to around 0.25 
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following unilateral vestibular neurectomy, in comparison to 0.8 on the intact 
side(125).  Gain asymmetry has been suggested as a method for quantifying 
abnormal VOR function, with one study indicating normal asymmetry to be less 
than 5.6% (123).  To quantify test results the examiner can use VOG or SSCR. 
Both systems export head and eye movement recording to a computer allowing 
for the calculation of gains.  
 
In clinics head impulse testing is often performed without quantification.  
Patients are instructed to sit facing the examiner who then grips the patients 
face, with thumbs on the zygomatic bone, fingers reaching around onto the 
mastoid	process	and	occipital	bone.		Patients	are	then	instructed	to	“fixate	on	the	
point	located	in	front	of	you”	(often	the	examiners	nasion)	while I turn your head 
to	 each	 side”.	 	 The	 examiner	 then	 turns	 the	 patient’s	 head	 to	 one	 side	 the	
patient’s	head,	aiming	for	rotation	velocities	of	above 150 °/s.  The presence of 
overt catch up saccades indicates vestibular hypofunction.  
 
To quantify test results the examiner can use VOG or SSCR.  In VOG the patient 
wears video goggles.  The examiner is located behind the patient and, and the 
thumbs are placed on the occipital bone, and the forefingers on the zygomatic 
bone.  When using SSCR the	patients’	eyes must first be anaesthetized before the 
search coils, imbedded in contact lenses are placed over their eyes.  Both systems 
export to a computer recording head and eye movement allowing for the 
calculation of gains.   
 
Head impulse testing is useful for identifying a unilateral vestibular deficit(126, 
127). Studies of such patients have shown consistent sensitivities of between 
34% and 39% when compared to calorics(128).  A canal paresis of greater than 
60% is often required for a positive HIT, with sensitivity increasing to 87% in the 
presence of a 100% paresis(111, 128). These studies corroborate the high 
specificity (100%) described by Halmagyi and Curthoys(122).  The low 
sensitivity (34-39%) and high specificity (100%) of HIT may be a consequence of 
how it is quantified.  Clinical observation alone cannot detect covert saccades or 
quantify gain.    While EOG measurements may be subject to muscular and 
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blinking artifacts.  The physician’s	 hands	 may	 also	 interfere	 with	 electrode	
recording. Horizontal resolution is limited to one degree(129). Until recently eye 
movement velocity and camera size limited the utility of video HIT.  New systems 
such as the have overcome these problems.  Accuracy in comparison to SSCR has 
been validated(104, 130, 131).   
 
HIT without video-oculography is well validated but reactive saccades indicating 
vestibular hypofunction may occur during the head movement.  These covert 
saccades cannot be picked up through observation alone, and video recording is 
required to maximise test sensitivity.  However, expense, difficulty of use and 
patient comfort has limited their clinical use.  
 
Ulmer et al (132) recently identified abnormal gains in the majority of patients 
with a canal paresis greater than 40% using HIT with VOG. These results 
highlight potential as an alternative to the calorics. Evidence is lacking with 
regard to the use of HIT in VS; that available is mostly observational studies with 
small sample sizes, investigating other types of vestibular lesions(133-135). 
 
2.3.5.3 Patient Induced Head Impulse Testing 
 
Active head impulse testing (Active-HIT) uses voluntary head rotation, aided by 
auditory cues. It activates the high velocity VOR using the same mechanisms as 
passive head impulse testing.  Eye movements are measured by either EOG or 
VOG and movement sensors characterise head movement.  The data acquired is 
used to derive VOR gain and phase shift, characterizing vestibular dysfunction.  
Several studies have highlighted the accuracy of Active-HIT in normal subjects; 
though test-retest reliability has been questioned. As the movements are patient 
driven, both anticipation and muscle activity (myogenic responses) influence the 
responses recorded.  
 
During active HIT patients are seated and instructed to fix gaze at a point ahead, 
before actively rotating their head from side to side; audio cues guiding head 
rotation frequency.  These cues allow the VOR to be tested at various 
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frequencies.  Eye movements are measured by either electro-oculography or 
video-oculography systems and movement sensors characterize head 
movement.  This data is used to quantify the gain and phase shift of the VOR so 
characterizing vestibular dysfunction.   
 
Strengths of active HIT include the lack of examiner input.  This minimises goggle 
slippage and associated movement artifact.   Also, compared to RCT it is cheaper 
and more portable.   However,one	concern	 is	 the	patient’s	capacity	to	generate	
sufficient head movement frequency, though Hervonen et al(136) have shown 
that 94% of patients can achieve a rotational speed of 4Hz and 78% can reach up 
to 5 Hz.  It has been suggested that patient anticipation and activation of 
concurrent myogenic responses may enhance the gain, especially during 
rotations below 2 Hz (137). Compared to calorics, lower sensitivity and 
specificity is reported(132).  While, feed forward motor planning from active 
head movements via the premotor cortex and the frontal eye fields may initiate 
eye movements increasing gain through non VOR mechanisms(138). 
 
Testing of VS patients post surgery showed significantly different gains between 
ipsilesional and contralesional sides(139).   However, in another study only 58% 
of patients showed abnormal gain(140). Lower sensitivity when compared to 
calorics indicates that Active-HIT is a poor stand-alone measure of vestibular 
hypofunction.  No studies were found that described utility in preoperative 
clinical management of VS.   
 
2.3.5.4 Rotational Chair Testing 
 
Rotational Chair testing was pioneered by Barany in 1907(141). Patients are 
secured in a chair designed to rotate at set frequencies; the stimulus may be 
sinusoidal or impulsive.   The stimuli induce endolymph flow and cupula 
displacement activating the VOR.  Rotational chair stimuli are limited to around 1 
Hz. The resulting compensatory eye movements are measured using EOG or 
VOG.  This information can then be used in conjunction with the chair angular 
 30 
velocity to calculate the gain and phase shift, which is then used to quantify 
vestibular dysfunction.   
 
Rotational chair testing allows for passive activation of the VOR.   Patients are 
strapped into a chair designed to rotate at set frequencies; the stimulus may be 
sinusoidal or impulsive.   The stimuli induce endolymph flow and cupula 
displacement activating the VOR. The resulting compensatory eye movements 
are measured using VOG or EOG.  This information is then used in conjunction 
with the chairs angular velocity to calculate the gain or phase shift (timing of eye 
movement in relation to head movement).  Vestibular dysfunction can then be 
quantified.   
 
Rotational chair testing is considered the clinical gold standard for 
characterizing bilateral vestibular hypofunction(25).  This is because both 
labyrinths are tested simultaneously and higher rotation frequencies can be 
employed. It has been shown to have greater specificity than but similar 
sensitivity to calorics (142, 143). 
 
Although well validated(25), the equipment is expensive, RCT is not portable and 
requires a large room area.  Consequently, it is often only available to specialized 
vestibular centers.   
 
Rotary chair testing stimulates both vestibular labyrinths simultaneously; as 
most VS are unilateral they are often better evaluated by tests that stimulate 
each	side	separately.				A	recent	study	has	suggested	that	“off	vertical”	axis	
rotations may be useful in investigation unilateral VS(144).  
 
2.3.5.5 Vestibular Evoked Myogenic Potentials  
 
Characterized as early as 1958, sound evoked myogenic potentials have been 
localised to the vestibular system(145, 146). These potentials are lost when the 
vestibular nerve is sectioned but remain present among those with 
sensorineural deafness(147). Either clicks or high frequency tones are conveyed 
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to the vestibular system by air or bone conduction, the latter is more reliable 
because any conductive hearing loss is circumvented.  This activates the 
vestibular system, inducing a reproducible myogenic response in the cervical, 
and extra-ocular muscles.  The cervical vestibular evoked myogenic potential 
(cVEMP) and ocular vestibular evoked myogenic responses (oVEMP) may be 
distinguished by recording activity in either the sternocleidomastoid (SCM) or 
oculomotor muscles. It is now generally considered that cVEMP is of saccular 
origin and oVEMP of utricular origin as the cVEMP is reduced following inferior 
vestibular neuritis, while the oVEMP is reduced in superior vestibular nerve 
lesions(148-150).  The oVEMP is mediated via the VOR whereas the cVEMP is via 
vestibular-colic pathways(151).  The oVEMP has a characteristic N1-P1 
waveform, with N1 at about 10ms and P1 at about 15ms; the waveform is 
described as n10-p15.  The cVEMP has a P13-N23 waveform that peaks at 13ms 
and 23ms. 
 
As the cVEMP is an inhibitory response the SCM muscle has to be active; to 
achieve this, the subject either raises their head off the pillow or turns their head 
to the non-test side. In contrast, oVEMP is an excitatory response and the eyes 
may be at rest during recording, but this response appears to be best recorded 
from the inferior oblique muscle with the subject looking upwards. 
 
VEMP dysfunction can be characterised by the presence or absence of response, 
calculating the asymmetry ratio between the amplitude of potentials generated 
from both ears (analogous to canal paresis in caloric testing), or comparing 
response latency.  
 
When measuring cVEMP the subject lies on a bed, surface electrodes are then 
placed on the SCM muscles.  An earth electrode is placed on the sternum and 
reference electrodes on the clavicles.  As the cVEMP is an inhibitory response the 
SCM muscle has to be active and the subject must raise their head forward. High 
intensity clicks (100dB-145dB) or induced vibrations (500HZ) are then 
presented to the test ear(148, 152).  A reproducible inhibitory waveform is then 
recorded via the electrodes; called the p13-n21, waveform(153).  To measure the 
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oVEMP surface electrodes are placed around the extra ocular muscles.  As this is 
an excitatory response the eyes may be at rest.  Ocular VEMP produces a 
characteristic n1-p1 waveform(151). 
 
Due to the new nature of VEMPs varying methodologies across studies mean that 
results are not readily comparable. Test results may be influenced by the degree 
of tonic neck muscle activation or gaze direction(152, 154).  This is difficult to 
maintain at constant levels.  A recent study has shown the capacity of cVEMP to 
identify vestibular dysfunction, with patients suffering from vertigo being more 
likely to have absent cVEMP compared to the control group(155). 
 
There are few studies of VEMPs in patients with VS. Abnormal oVEMP have been 
reported in 70% to 80% of VS patients, as few as 37.5% of patients in one 
study(147, 148, 156).  Chiarovano (152) identified abnormal oVEMP in nine of 
12 patients, but only 50% had an abnormal cVEMP; there was weak correlation 
with canal paresis.  However, despite this the mean waveform latencies were not 
significantly different from normal. This suggests that while oVEMP is potentially 
superior for monitoring VS, it still has limited usefulness.   
 
Several studies have shown no significant difference between calorics and VEMP 
when investigating for VS, both tests showing a sensitivity of 80.8%, but 
specificity was only 52.7%(157). Test sensitivity is affected by the stimulus used 


















(Relative to bi-thermal 
Calorics) 
300 C: 86%(117) 
440 Cs: 82%(117) 
300 C: 80%(117) 
440 C: 78%(117) 






(42/150 patients with VS): 
34%(128) 


























Table 1:  Sensitivity and Specificity for different vestibular testing 
modalities in identifying vestibular hypofunction in patients with 
vestibular schwannoma 
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2.3.6 Other Tests in Vestibular Schwannoma  
 
2.3.6.1 Dizziness Handicap Inventory 
 
The Dizziness Handicap Inventory (DHI) comprises 25-questions that aim to 
relate patients’ perceived handicap for everyday tasks due to vestibular disease.  
Patients are administered the 25 questions by the examiner.  It needs to be 
clearly outlined that the questions should only be related to dizziness, rather 
than other functional handicaps.   
 
The DHI can be broken into three sub categories assessing physical, emotional 
and functional capacity.  Each question is answered yes, sometimes, or no. 
Responses  are scored 4, 2, or 0 respectively giving a total possible score of one 
hundred.  A total of less than 25 indicate around 12 or fewer balance 
disturbances per year.  A score between 25 and 34 indicates greater than 12 non-
continuous balance disturbances throughout the year, greater than 49 indicates 
near continuous balance disturbance. In the seminal study it showed good 
internal consistency, test retest reliability was high and mean DHI score 
increased with increasing dizziness(160).   Further studies have shown that DHI 
correlates with some balance function measures(161).  The DHI allows for the 
assessment	of	 the	 functional	 impact	 that	dizziness	has	on	a	patient’s	 life.  This 
can inform clinical decision-making.   
 
Principal component analysis of the DHI subcategory called into question their 
validity as individual measures (162). This should be taken into consideration 
when using subcategories to highlight a particular area of patient morbidity.  
 
Wagner et al found no correlation between DHI scores and tumour size in 
patient’s	 vestibular schwannoma(163).  Though women were found to have 
significantly higher DHI than men, with 75% of patients having some degree of 
functional impairment.  It is worth nothing that this study includes the 
intrameatal portion of the schwannoma when measuring its size.  A further study 
reported the median preoperative DHI score to be 30, with age not a significant 
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factor in determining DHI scores(164).  Another study found that for 
schwannoma less than 20mm diameter, the median DHI was 32, but in tumours 
large than 20 mm the median DHI was 20(162). The DHI could not be predicted 
from tumour size but the degree of preoperative canal paresis could be used to 
predict DHI outcome following surgical intervention(163).  
 
Tumor size, sex, and magnitude of preoperative canal paresis significantly 
influence the degree of change in DHI following surgery. Age, the presence of 
central vestibular system abnormalities, and the nature of the patient's principal 
presenting symptom have no effect on DHI score following surgery.  Use of the 
DHI in preoperative monitoring allows for assessment of schwannoma vestibular 
impact on quality of life.  This is important as vertigo and dizziness strongly 
affect quality of life.    Balance disturbance is the most significant audio 




Audiometry is used to assess a patient’s degree of hearing function. Full testing 
includes assessment of middle ear function, hearing threshold and speech 
discrimination scoring.    
 
Pure tone audiometry (PTA) scoring indicates the quietest sound detectable by 
the individual 50% of the time the stimulus is presented.  It is performed using 
an audiometer, and both bone and air conduction is tested at frequencies ranging 
from 0.25 to 8 kHz.  The intensity of the stimulus is recorded in decibels hearing 
level (dbHL).  Results are then represented graphically; high frequency 
deterioration is often seen in aging.   When summarizing left or right ear hearing 
threshold a pure tone average can be used, often this is average across 
frequencies 0.5, 1, 2, and 4 kHz(81). 
 
Speech discrimination testing investigates the capacity of the patient to 
recognize and understand set of 25 words.  The number of words that the patient 
can correctly repeat is presented as a percentage.  
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Gardner-Robertson scoring is used to combine PTA and speech discrimination 
score results (Table 2).  Test results are scored are graded I to V scale, based on 
speech discrimination percentage and PTA results.   A score of V indicates 







Grade PTA (dB) SD (%) 
I: Good 0-30 70-100 
II: Serviceable 31-50 50-69 
III: Non-Serviceable 51-90 5-49 
IV: Poor 90-100 1-4 
V: Deaf 0 0 
PTA = Pure tone average 
SD = Speech Discrimination Score  
Table 2 Gardener-Robertson scoring allows for objective evaluation of the 
degree of function hearing impairment suffered by the patient. 
 
 
Table 2: Gardener-Robertson Hearing Scale 
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Multiple mechanisms underlie hearing loss, including blockage of the external air 
canals, middle ear effusions, cochlea damage and congenital disorders.  Used in 
conjunction these tests can identify the type and degree of hearing loss present.   
Testing in VS normally consists of pure tone audiometry and speech 
discrimination scoring.  The resultant scores are than tabulated to produce an 
overall hearing grade (Table 2). 
 
In VS the most common presenting symptom is unilateral sensorineural hearing 
loss audiometry quantifies this.  Rapid onset unilateral sensorineural hearing 
loss is a key red flag for the presence of vestibular schwannoma.  Repeat 
audiometric testing can then be used to monitor for deterioration in hearing that 
may be an indicator for intervention.  
 
Hearing thresholds have been shown to decline regardless of tumour growth 
rates, but may deteriorate faster in quickly growing tumours (53).   Reports on 
the correlation between growth rate and audiometry test results have been 
conflicting, with some indicating there is correlation, and others not(166-169). 
 
Hearing loss documented by audiometry is seen in almost all VS patients; 
characteristically this is a sensorineural hearing loss.  Indeed unilateral hearing 
loss, with a mass lesion in the cerrebellopontine seen on MRI is the diagnostic 
hallmark of VS.  It has been highlighted that tumours with lower growth rates 
had significantly higher rates of hearing preservation.   Tumour size is also a 
predictive factor for postoperative hearing loss(170, 171).  
 
2.3.6.3 Cognitive Testing 
 
Cognitive function testing is not routinely undertaken tests in patients with VS or 
vestibular lesions.   Regardless, physicians frequently note patients suffer from 
short-term memory loss, lack concentration and frequently have difficulty with 
multitasking(26). However, it must be noted that vestibular dysfunction does not 
result in general cognitive impairment. Animal studies utilizing single neuron 
recording have highlighted that both the cortex and hippocampus receive direct 
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vestibular input (29, 172).     Animals with defined vestibular lesions show 
decreased capacity to perform tasks that require spatial memory, for example 
navigating water mazes (27). Studies of humans using PET scanning have also 
shown increased cortical and hippocampal activity following caloric stimulation 
of the vestibular system(28). In humans one study has shown that patients with 
bilateral vestibular lesions suffered a 16.9% decrease in hippocampus volume 
relative to controls(30). It has also been highlighted that humans with vestibular 
disorder display cognitive effects, with decreased capacity to complete tasks 
such as backward counting when compared to normal(173).  The weight of 
evidence indicates that vestibular lesions can have cognitive impact.   Given the 
significant links to the hippocampus this is likely to be in the form of spatial 
memory and spatial orientation. This fits with the clinically suggested short-term 
memory loss, and multitasking that requires switching between objects in space. 
These mechanisms could underlie some of the functional difficulties present 
following vestibular lesions.    Better understanding of these mechanisms could 
lead to improved interventions and outcomes following vestibular lesions.  
Currently targeted cognitive testing is not clinically performed in monitoring 
vestibular patients and no studies could be found investigating cognitive deficit 
in those with long standing vestibular schwannoma.   
 
2.3.6.4 Magnetic Resonance Imaging (MRI)  
 
Magnetic resonance imaging with gandolinium enhancement is considered the 
clinical gold standard imaging technique for vestibular schwannoma(174). 
Computed tomography scanning is limited to diagnosis a 10 mm diameter lesion 
unless air contrast is used. 
 
Following scanning tumours are classified as intracannalicular or 
extracannalicular and measured using a sub-millimetre digital ruler.  Multiple 
quantification techniques exist for measuring tumour size.  The American 
Academy of Otolaryngology Committee on Hearing and Equilibrium states that 
the diameter of the tumour should be measured parallel to the petrous ridge for 
extra cannalicular tumours(175).  A second measurement can then be taken 
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perpendicular to this.  Other proposed diameters include the anteroposterior, 
mediolateral and craniocaudal dimensions (176, 177). Intracannalicular tumours 
are quantified by measuring length along the internal auditory canal.  Tumor 
volume can then be calculated using these measures.  Full three-dimensional 
quantification can be performed by manual segmentation, circumference tracing, 
and computer automated grey shade differentiation (176, 178). Two-
dimensional measures have shown to correlate relatively poorly with full three-
dimensional measures(179). This is likely to due to the fact the calculations used 
to derive volume from diameter assume that the VS is spherical in nature, which 
is not always the case.   
 
Overall there is good inter scanner reliability, allowing for comparison of MRIs 
from different centers (180). Luppino (178) et al suggested that there is a low 
degree of inter-observer reliability using a manual process, with intra-observer 
reliability dependent on examiners expertise and experience.  Decreasing the 
slice thickness from 3mm to 1mm on MRI has shown to increase accuracy of 
tumour sizing (178).    
 
Annual growth of 1.16mm of VS is held to be significant by the American 
Academy of Otolaryngology-Head and Neck Surgery(175).  One study stated that 
the smallest detectable difference is 1.1mm linearly (181).  However, this lies 
within the margin of measurement error, and therefore should not drive clinical 
decisions.  This is particularly important for small tumors, where a small 
absolute increase in size can represent a significant proportional increase in 
volume.   
 
Considered the gold standard for diagnosis of vestibular schwannoma, MRI scans 
allow for quantification of tumour size that informs management decisions.  As 
well as this MRI scanning allows of monitoring of tumour growth.  Tumour size 





2.3.7 Localising Nerve of Origin  
 
It has been suggested that a combination of vestibular tests may be used to 
localize the VS nerve of origin(182).  The superior vestibular nerve carries fibres 
from the anterior canal, lateral canal and utricle, whereas fibres from the 
posterior canal and saccule run in the inferior vestibular nerve.  Theoretically, 
tumours arising from one or other nerve would preferentially affect that nerves 
response and be reflected in the responses recorded in different tests. For 
example, a tumour arising from the superior vestibular nerve may be expected to 
reduce responses to Active-HIT, calorics, oVEMP or rotational chair testing, while 
the cVEMP remains normal. The converse would be expected for an inferior 
vestibular nerve schwannoma. Thus, cVEMP combined with either Active-HIT or 
calorics may allow identification of the tumour nerve of origin.  This may aid 
selection of surgical approach when planning hearing preservation surgery.   
 
No studies were found that used HIT or RCT to localize the nerve of origin. Chen 
et al found VEMPs useful to predict VS nerve of origin prior to surgery(183).  A 
more recent study using VEMP and calorics have shown poor correlation 
between test results and nerve of origin(184). 
 
2.4 Treatment Methods 
 
2.4.1 Monitoring:  the “Wait and Watch” Approach 
 
Increased early identification of small tumours due to advancement in scanning 
techniques	 has	 led	 to	 an	 increase	 in	 the	 “wait	 and	 watch”	 approach	 in	 VS	
management.  The increasing number of small tumours identified and questions 
surrounding the impact of intervention as well as tumour growth rates on quality 
of life has further popularized this method(74, 185). 
 
Poor health, patient age, patient preference, small tumour size and lack of 
symptoms are the key selection criteria.  Following adoption of this approach 
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patients undergo annual MRI scanning to monitor for tumour growth.   It is 
argued that because VS are slow growing in nature this approach avoids 
unnecessary surgical morbidity(186, 187).    
 
One case series found failure of treatment in 13.4% of cases, defined as where 
active intervention was required(188).  In contrast to this treatment failure was 
seen in 74% of patients in a smaller study following with five years of follow 
up(189). Treatment failure was defined as necessary surgery.  About one half to 
one third of conservatively managed patients develops hearing loss over three 
years regardless of tumour growth.   
 
2.4.2 Radiotherapy in Vestibular Schwannoma 
 
Radiotherapy as an alternative to microsurgery was first used in 1969(190).  In 
the past forty years it has become an important method of treating small to 
medium sized VS.  Stereotactic radiotherapy (SRT) was initially the 
recommended intervention (190). Recent studies, however, suggest that 
fractionated stereotactic radiotherapy (FRT) may result in better long term 
hearing preservation although this has not been fully validated(191).  Higher 
resolution MRI and treatment planning software has allowed for better targeting 
of isodose centers(192). 
 
SRT utilizes a stereotactic frame to immobilize	 the	 patient’s	 head to allow for 
targeted dosing of the tumour.    Dose targeting and quantification is then 
calculated from MRI scans.  A single dose of around 14 GY ionizing radiation is 
administered with the goal of arresting tumour growth(193). Tumour growth is 
arrested 89.2%-96.8% of the time following SRT, with the volume doubling time 
decreasing from 1.36 years to 13.1 years(194).  Hearing preservation rates have 
ranged from 58%-90%; a systematic literature review concluded hearing 
preservation is around 61% in doses of less than 13Gy and decreases to between 
40% and 50.4% when doses of greater than 13 GY are used(195).  Treatment 
failure including surgical intervention and continued growth rate has ranged 
from 2% to 13%(196, 197).  The VII cranial nerve is intimately related to the VS 
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capsule and is particularly at risk from treatment.  Rates of facial nerve 
dysfunction range from 0% to 5.2%. Patients undergoing SRT are said to lose 2.5 
days of work following therapy(198). The lack of large comparative studies and 
RCTs mean that level one and two-evidence is lacking.    Frequently smaller 
tumours, in which hearing preservation is possible, are selected for 
radiotherapy.  This selection bias is likely to result in increased rates of hearing 
preservation post radiotherapy.  Regardless, SRT shows good efficacy in treating 
small to medium sized tumours.   
 
Fractionated stereotactic radiotherapy was initially used as a post surgical 
adjunct in VS.  Recently several studies have demonstrated its usefulness as a 
stand-alone treatment measure(199-201). Fractionated stereotactic 
radiotherapy differs from SRT in that it utilizes several summative radiation 
doses to achieve the total desired dose.  It is thought that doing so allows normal 
tissue to recover from the small dose it receives between sessions.  This allows 
for much higher summative doses (Up to 2GY per session, 5 sessions per week, 
giving up to 60GY total dose).  Fractioning in this manner also reduces tumor 
swelling sometimes seen post treatment. This is a concern in large tumors that 
already show mass effects (202). 
 
Local control rates, defined as no tumor growth, have ranged between 86%-
100%.  Hearing preservation varies between 57% and 93% with auditory 
dysfunction seen in between 0%-4% of cases, and facial dysfunction between 0% 
and 4%(200, 201, 203).   These results are comparable to those from SRT.   In 
contrast, FRT requires a much greater time commitment from both the patient 
and oncology team than SRT.  
 




The first vestibular schwannoma was described following post mortem in 1777 
(204).  Not until 1810 were symptoms ascribed to this pathology, when facial 
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palsy, vestibulopathy, dysarthria, tinnitus and mass effects were described (205).  
However, it took until the end of the early 19th century, for the tumour to be 
localized based on patient symptoms.  Charles Balance performed the first 
successful removal of vestibular schwannoma in 1894. Subsequently the 
suboccipital approach, now known as the retrosigmoidal approach, was 
described by Krause (206).  The first translabyrinthine approach to was made in 
1904(206).  At this time problems associated with hemorrhage, dissection 
technique, equipment, and lack of imaging meant that mortality rates often 
exceeded 80%. As cautery, anesthesia, and blood replacement were introduced 
as well as the use of ventricular taps to lower CSF pressure mortality following 
total tumour removal began to fall.  Bill House reinvented the translabyrinthine 
approach before the middle fossa approach was popularized.  In the following 
years advancement of technology has lead to better pre, post and intraoperative 
management of VS patients.  Preoperatively the advent of pantopaque x-ray 
contrast allowed for better localization of tumour(207). The subsequent 
development of CT and then MRI has allowed for better quantification of tumour 
size.  
 
Furthermore the surgical microscope, diamond burs and irrigative suction allow 
for better access to and visualization of the surgical field.  This coupled with 
intraoperative nerve activity recording has allowed for better identification and 
management of facial nerve function.    Postoperatively improvements in surgical 
technique and technology have led to fewer postoperative complications.  The 
cumulative advancements in vestibular surgery have led to a fall in mortality 
rates. 
 
2.4.3.2 Translabyrinthine Approach  
 
The translabyrinthine approach is frequently used in patients when there is little 
chance of retaining useful hearing.  A hockey stick shaped incision is made two 
and a half centimetres posterior to the post auricular sulcus.  The skin flap, 
underlying muscle and fascia is reflected and a mastoidectomy performed.  
Following identification of the facial nerve and lateral SCC a labyrinthectomy is 
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performed.  The internal auditory canal is identified and the bone dissected away 
to allow access.  At this stage important anatomical landmarks are again 
identified, and the facial nerve identified using a facial nerve stimulator.  
Subsequently, the tumour is debulked and dissected away from the facial nerve.  
Following this the posterior fossa dura is repaired and the wound is filled with 
fat, taken from the abdomen, and then sealed.    
 
The translabyrinthine approach offers the most direct route to the 
cerrebellopontine angle and exposes the entire internal auditory canal(208).  
Furthermore little or no retraction the cerebellum is required, and the size of the 
tumour is not a limiting factor(209) 
 
Several case series describe negative outcome rates as CSF leak 0.9%, 
Meningitis 0.1%, Intracranial bleeding 0.8%, Non VII/VII nerve palsy 1.0%, 
Cerebellar Ataxia 0.7%, Death: 0.1% (210). 
 
2.4.3.3 Retrosigmoid Approach 
 
The retrosigmoid approach uses a vertical or slightly curved vertically orientated 
incision placed posterior to the sigmoid sinus.  Subsequently, an occipital 
craniotomy is performed, and the dura and arachnoid mater opened.  Because of 
the angle of approach, the cerebellum had to be retracted; corticosteroids, 
mannitol and hyperventilation were used to reduce retraction. Better 
instrumentation and CSF release from the basal cistern has meant that very little 
cerebellar retraction is required. Following retraction the tumour is identified 
and debulked.  The seventh and eight cranial nerves are usually situated on the 
anterior surface of the tumour; therefore care must be taken not to inadvertently 
damage these during debulking, this is facilitated by identifying the nerves as 
they exit the brainstem and using the facial nerve stimulator to confirm that the 
facial nerve is not running more posterosuperiorly  than expected..   Following 
tumour debulking the internal auditory canal can be accessed using a high-speed 
drill to remove bone over its posterior aspect , this allows identification of the 
facial and cochlear nerves so that the  intracannalicular portion of the tumour 
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can be removed while preserving their integrity.  From here the tumour is 
carefully dissected away.   Following removal, the internal auditory canal is 
packed with soft tissue (fat and or muscle), the  dura is closed and a cranioplasty 
is performed.   
 
A case series by Samii et al (211)resulted in 0% mortality rate, 2% CSF leak, 
anatomical preservation of facial nerve in 98.5% of cases, and functional hearing 
preservation in 51%.  
 
2.4.3.4 Middle Cranial fossa approach   
 
An	inverted	‘U’	 incision is based and centered superior to the external auditory 
meatus allows exposure of the squamous temporal bone, and a middle fossa 
craniotomy is performed.    The dura can then be elevated off the floor of the 
middle cranial fossa and temporal bone.   Following this the internal auditory 
canal is ‘skeletonised’, and opened. Different surgeons utilize various landmarks 
used to identify the internal auditory canal.  Subsequently the dura of the 
internal auditory canal is opened and reflected exposing the contents.  The 
tumour is identified and the plane between the tumour and facial nerve clearly 
delineated.   Similar to other approaches tumour removal begins with debulking, 
until enough space is present to carefully dissect the tumour away from the facial 
nerve.   Following tumour removal the dura is replaced over the IAC,  and mini-
plates are used to replace the squamous temporal bone that was removed during 
the initial craniotomy and the wound is closed.   
 
Arts et al (212) using the middle cranial fossa approach reported House 
Brackman facial nerve function of I/II in 96% of cases, and 62% of cases 
retaining rate of class A hearing . A case series by Gjuric M et al (213) resulted in 
a 0.4% mortality rate, CSF fistula in 2.2% of cases and meningitis in 1.2%.   
Improved outcomes were found with increasing surgical experience, with the 
last 254 cases resulting in no incidences of mortality, CSF fistula or meningitis.  
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2.5 Treatment Selection  
 
Deciding on when and how to intervene is influenced by a variety of factors.   The 
most commonly stated factors include tumour size, desire for hearing 
preservation, patient expectation and individual decision(214); with small 
tumour size and older age being common predictors of conservative treatment.  
Usually vestibular function and post surgical quality of life scores are not taken 
into account.   The primary determinant of clinical outcome is tumor size at the 
time of intervention. Furthermore, traditional vestibular testing methods have 
shown little capacity to localize tumor origin, VEMPs have shown greater 
promise but more investigation is needed.  The capacity to determine the nerve 
of origin may optimize the selection of the surgical approach, particularly for 
smaller tumors.   
 
The primary potential clinical utility of vestibular testing in vestibular 
schwannoma lies in the capacity to quantify vestibular hypofunction, 
information that can be used to assist clinical decision-making; this is not current 
clinical practice.  Assessing vestibular function prior to intervention may predict 
how much balance disturbance patients experience post-surgery, and the impact 
this may have on their return to full activites.  If this is the case then pateints 
likely to experience severe vestibular dysfunction could receive early input from 
a physiotherapist with exerpeince in vestiblar dysfunction.  Input could include 
vestibulo-ocular reflex strengthen exercise that may shorten the recovery time, 
resulting in a quicker return to full activities.        
 
Access to these tests has been limited by both cost and their clinical limitations.  
Newer testing methods such as HIT with VOG are quicker, easier, more 
comfortable to administer, and give the opportunity to more readily integrate 
vestibular function testing into VS monitoring and management.  
 
It has been shown that the discipline of the attending surgeon was a predictive 
factor for the choice of treatment(215).    This may also	 influence	 the	patient’s	
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decision making.   Comparing significant case series is difficult.   Though each 
surgical approach is well established there is still inter-surgeon variation in 
techniques. While preoperative selection of patients likely to show good 
outcomes is likely to increase the success rates and minimize morbidity.  
 
 A 2012 systematic review concluded that middle cranial fossa approach is 
advantageous for hearing preservation in patients with small tumours(209).  The 
translabyrinthine approach may be employed when there is no expectation of 
hearing preservation. While the retrosigmoid approach is appropriate for most 
tumours it also results in the highest rate of CSF leak. 
 
 Stereotactic radiotherapy has been shown to have better tumour control rate 
when compared to the watch and wait approach.  This is a somewhat self-
evident outcome as frequently patients who receive SRT are treated prior to 
tumour growth, or demonstration of lack thereof.  In contrast patients who 
follow the watch and wait approach receive intervention following 
demonstrated tumour growth; with those not demonstrating growth not 
requiring SRT.  This has both cost and health implications for the patient and 
society.  
 
Current management protocols suggest the following management algorithm. 
Tumours and those below 20 mm intracranial diameter with no growth or, single 
observation, should follow conservative treatment.  Tumours less than 20 
millimeters with demonstrated growth should have radiotherapy or surgery.  
Tumours between 20-25mm on single scan should have radiotherapy or surgery 
and those greater than 25 mm on a single scan should have surgery(54).   
 
Traditional vestibular testing methods have shown little capacity to localize 
tumour origin, VEMPs have shown greater promise but more investigation is 
needed.  The capacity to determine the nerve of origin may optimize the 
selection of the surgical approach, particularly for smaller tumours.   
 
Regardless, operative decision-making should be made on a case-by-case patient, 
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as this allows the informed decision-making, taking into account the full 
spectrum of functional tests as well as the patient’s needs and wishes. Vestibular 





3.1 Study Design 
 
A non-blind observational study was undertaken.  Study endpoints were either 
one or two separate participant measures. These took place in March/April 2013 
and September/October 2013.   Testing took place in the Dunedin Hospital, 
Dunedin, Dunstan Hospital, Clyde and Southland Hospital, Invercargill.  The 
primary purpose of the study was to validate a relatively new method of 
vestibular function testing, iral recording video HIT in comparison to calorics.   
 
This study took place as a BMedSci (Hons) thesis project under the auspices of 
the Dunedin School of Medicine.  Supervised by Dr. Nicholas Cutfield, consultant 





The University of Otago Human Ethics Committee approved the study; reference 
code 12/303 (Appendix 9.1). 
 
Maori consultation was also sought with the Ngai Tahu Research Consultation 




3.3 Recruitment  
 
The study population was drawn from diagnosed vestibular schwannoma 
patients under the care of A/Prof Patrick Dawes.   Consisting of New Zealanders 
living in the Southern District Health Board catchment, an initial sample size of 
30 participants was targeted.    
 
Participants were recruited by informal approach by post.  Parcels contained a 
brief introductory letter and the University of Otago Ethics Committee approved 
information sheet (Appendix 9.3).  Following this potential participants were 
contacted by telephone to assess interest.  Questions and concerns were 
addressed at this time, potential participants were screened for exclusion 
criteria (Table 3), and verbal consent was obtained.  If the participant consented 
to take part an examination time was arranged.   A second call served to remind 
participants of the study two days before they were scheduled.  Informed 






















Inclusion Criteria Exclusion Criteria 
x Any adult subject able to give 
informed consent diagnosed 
with unilateral vestibular 
schwannoma and who had not 
had this surgically removed. 
x Any subject unable to give 
informed consent 
x Inability to lie still for 20 
minutes. 
x Individuals in whom caloric 
and/or head impulse testing is 
contraindicated. 
x Severe structural neck 
problems 
x Severe narrowing of the spinal 
canal 
x Perforated Air drum 
x Congenital Nystagmus 
x Blindness 
x Bilateral vestibular 
schwannoma 
x Central pathology 
x Other vestibular pathology 
x Migraine 
x TIA 
x Multiple Sclerosis 




Table 3 Legend: Inclusion and Exclusion Criteria:  Exclusion criteria 
were selected to minimize the chance of bias or confounding factors in 
the data set while maximizing participant safety. 




A total of 42 potential participants were contacted over the course of the study.  
10 declined to participate. Their reasons included living out of Dunedin, other 
medical surgery planned, shifting hometown and anxiety about caloric testing 
(n=5).   Of the 32 participants that agreed, data from one participant had to be 
excluded; this was due to the presence of congenital nystagmus.  The remaining 
31 met the inclusion criteria.    
 
Vestibular function testing was performed in 31 participants that met the 
inclusion criteria with unilateral vestibular schwannoma, 13 of which were 
female. Subjects were used as their own controls, the unilateral nature of the 
vestibular schwannoma allowing for comparison between sides.   Audiometry 
testing was only performed in 10 cases due to renovation of the Dunedin 
Hospital Audiology department.  Repeat testing was performed in 10 subjects to 
show repeatability, mean age 63.9, five of which were female.  No participants 
had consumed alcohol within 24 hours of testing.  No negative outcomes 
occurred throughout the testing, and no participant suffered an adverse event.   
 
3.5 Testing Measures 
 
3.5.1 Audiometry  
 
The Audiology Department at the Dunedin Public Hospital performed the pure 
tone audiometry testing, following a standard protocol(216). Testing was 
performed across frequencies 0.25 to 4 kHz.  Thresholds were recorded in 
decibels hearing level (dBHL). A pure tone average was then calculated across 
0.5, 1, 2, 4 kHz frequencies(81).  The Gardner-Robinson scoring criteria could 
not be calculated as resource limitations meant that speech audiometry testing 




3.5.2 Dizziness Handicap Inventory  
 
Study participants completed the DHI(160)(Appendix 9.5). It was specified that 
dysfunction should only be in relation to dizziness and that the impact of other 
factors, such as hearing loss, should not be taken into account when answering 
the questionnaire.  
 
3.5.3 Quantitative vHIT Testing 
 
Quantitative HIT was performed in Dunedin, Clyde, and Invercargill.  
Participants were instructed to sit up right on a chair, with a fixed back support 
to avoid whole body rotation, approximately 1.5 meters from the fixation target 
to avoid fixation effects.  Being close to the fixation target can increase gain as 
eye convergence increases the VOR(217).  The same chair was used for each test.  
The patients then put on the EyeSeeCam goggles (Munich, Interacoustics)(Figure 
6,7).  These consist of a lightweight (60g) infrared camera, with integrated 
inertial sensor mounted on plastic goggles which record head movement and eye 
position signals at high frequency (200Hz).  The camera’s lightweight and firm 
scalp attachment mean slippage is minimized, a problem with older, heavier 
cameras.   The camera is adjusted to	fully	identify	the	participant’s	pupil	and	the 
equipment measurements are calibrated as follows.  The participant was 
instructed to sequentially fixate on 5 luminous dots projected by the EyeSeeCam 
at predefined angles of 8.5 degrees, with the central dot located on the fixation 
target, a four by four centimeter cross.  A clustering algorithm detects these 
fixations, which are then localized within the software program.  The parameters 
are then stored in Matlab and exported as a diagram.  This is then checked 
manually to ensure appropriate fixation has taken place.  If fixation was deemed 
to be inappropriate calibration was repeated.    
 
Participants were then instructed to sit as still as possible while fixing vision on a 
target placed in front of them, keeping their eyes wide open and not blinking. It 
was explained that several movements of the head from side to side would be 
made.  The need to not anticipate head movements and to relax their neck was 
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reinforced.  The examiner than firmly placed their hands on the occiput and 
zygomatic bones, three practice impulses to each side were performed.    
Recording was then started and a minimum of 10 impulses to each side at 
velocities of 150 °/s or above were performed.  These were performed in a 
pseudo-random order with a variable inter-test interval (0.5-4s) to avoid any 
anticipatory eye movements.  Impulses were finished once an appropriate 
number had been performed, up to thirty to each side.  The infrared camera 
recorded eye moment by tracking pupil location, while the inertial sensor 
quantified head movement. The eye position signal from the EyeSeeCam was 
then ported to matlab where it was differentiated to give an angular eye velocity 
(°/s).  Simultaneously head acceleration was recorded and integrated giving an 
angular head velocity.   This too was exported to matlab and presented in EyeSee 
software.  Vestibular ocular reflex gain was calculated (at 60ms after onset of the 
impulse), the signals were then analysed as velocities.  The VOR gain across 
multiple impulses was averaged to give a final figure.   Where signal was 
impeded due to excess noise such as narrow palpebral fissure, long eyelashes, 
blinking, reflexive excessive pupil dilation or goggle slippage the head impulse 
testing is repeated until an accurate measure was generated. Sensitivity and 
specificity of HIT was calculated in comparison to caloric testing.    This assumed 
a caloric canal paresis of 0.20 or greater is significant.    Initially a HIT gain of < 
0.74, was used.   However, given the lack of literature on what is truly 
pathological in HIT testing, sensitivity and specificity was also calculated using 
more relaxed thresholds of significance, i.e. 0.92. This was to determine if 
currently accepted value, 0.74, lacked sensitivity in identifying vestibular 
dysfunction Gain asymmetry was also calculated in a manner analogous to 
Jongkees formula;  IpsilesionalGain  ContralesionalGain
IpsilesionalGain+ContralesionalGain
. Gain asymmetry of 
greater than 5.6% was held to be pathological.  This values was based on one 
research paper by Schmid-Priscoveanu et al (123) as the use of gain asymmetry 





3.5.4 Caloric testing 
 
Caloric testing was performed using the Aquastar 2.0 Irrigator Water (Difra, 
Welkenraedt) (Figure 8) following the Fitzgerald and Hallpike method(109).  
Participants were instructed to lie down on an examination bed with their head 
raised at 30 degrees to the horizontal to bring the lateral canal into the plane of 
irrigation.   Participants were then advised that irrigations of cool to the 
contralesional and then ipsilesional, followed by warm to the contralesional and 
then ipsilesional would take place, highlighting the need to look straight ahead, 
with eyes wide open and not to blink.  Calibration was analogous to that 
undertaken in vHIT.  Opaque lenses were then inserted into the goggles placing 
the participants in the dark to avoid visual fixation, which will reduce 
nystagmus(218).  Throughout testing participants were reminded not to blink, 
look straight ahead and to keep their eyes wide open.  It was explained that the 
dizziness might last for up to two minutes, reach a peak then decrease.  In order 
to ensure patient comfort cool irrigations were performed prior to warm 
irrigations.   This was decided on clinical grounds as no clinically significant 
systematic bias in the induced caloric response can be related to order of 
testing(219).   Irrigations were delivered at 30 °C ± 0.4 °C and 44 °C ± 0.4 °C via a 
decontaminated silicon irrigator nozzle(220).  Irrigations lasted for 30 seconds 
and 250 ml ± 10 ml at 1.5 bar was delivered(221).  Recording continued for 
three minutes after this, with a 7-minute interval between irrigations to avoid 
fatigue and summative effects.   Good irrigations were confirmed via patient 
report of vestibular sensation of vertigo or vection, degree of wax dislodged 
during the irrigation, the angle of the waterspout back from the ear, and 
tympanic rubor.   The 95% confidence limits for individual irrigations are 
typically 5 °/s and 57 °/s with the more marked nystagmus often seen following 
warm irrigation compared to cool(219). Patient alertness was maintained by 
simple conversation throughout the recording period(222).  If significant doubts 
existed about the quality of the irrigation or the recording was a poor, i.e. 
insufficient mental alertness, inconsistent nystagmus, repeated blinking the 
suspect irrigation was repeated following the four standard irrigations.  
Nystagmus recordings were exported to matlab via EyeSeeCam and represented 
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graphically via ezeeye software (Munich, Interacoustics).  The average peak slow 
phase velocity was taken from the ezeeye software graph.  The canal paresis was 
then calculated according to Jongkees formula.  A caloric canal paresis of 0.2 was 
considered to be pathological.  
 
3.5.5 Cognitive Testing 
 
Cognitive testing was performed using the CANTAB Cambridge cognition 
platform (223).   The battery followed, Motor Screening Task, Big/Little Circle, 
Intra Extra Dimensional shift and Paired associates learning.  Each test was 
administered using the standard script from the CANTAB eclipse 5 Test 
Administration Guide Version, Cambridge Cognition Ltd (2011) supplied with 
the CANTAB system to ensure the same instructions were given to each 
participant.  Outcome measures including latency of response, number of errors, 
number of trials and stages completed were then compared to the reference 
normal groups taken from the literature to ascertain abnormal function(224). 
 
3.5.6 Schwannoma Dimensions 
 
All participants whose MRI scans of the cerrebellopontine angle were available 
were analyzed retrospectively for tumour size.  All examinations were 
performed on 1.5 Tesla MR scanners (GE, Milwaukee) and with the measured 
scans consisting of T1 weighted gadolinium enhanced scan with slice thickness 
of 2-2.5mm.  All patients underwent imaging following Southern District Health 
Board protocol for MRI. 
 
Tumour size measurements were performed on ‘Radiology measuring stations’ 
following advice from a Consultant Radiologist.  Measurements were performed 
using a submillimeter digital ruler.   Measurements were taken at the largest 
observed schwannoma size in the axial and coronal planes.    Blinded repeat 
measures were performed at later date to ensure intra observer reliability.   
Measurements were taken in the anteroposterior, transverse and longitudinal 
axes. This is consistent with measuring the greatest AP dimension in 
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extracannalicular schwannoma and longest dimension in the plane of the canal 
in intracannalicular, consistent with the published protocol(225).  Tumors were 


































































Small 1-10mm extrameatal 
Medium 11-20mm 
Moderately large 21-30mm 
Large 31-40mm 
Giant >40mm 
Table 4 Schwannoma Classifications  
 
Table 4 Legend: Measurements are taken along anteroposterior 
dimension for extracannalicular tumours 


































Figure 8: Aquastar Caloric Irrigator 




Participants were screened for exclusion criteria prior to testing.   Following this 
non-excluded participants were then tested.   ten participants underwent second 
testing to show repeatability.  This was due to the study  time frame, patient 
preference,  as well as resource limitations.  The rationale for the repeat testing 
was to ensure measurement repeatability and to confirm the stability of the 
vestibular dysfunction when cognitive testing was performed  
 
3.6.1 Test One 
 
Standard Examination Procedure: 
1. Create new password protected participant data file 
2. Informed Consent  
3. Audiometry testing performed by the Audiology Department, Dunedin 
Hospital.   
4. Dizziness Handicap Inventory questionnaire  
5. Seat participant 1.5m from target  
6. Mount goggles on the patient, align camera  
7. Calibrate EyeSeeCam 
8. 3 Head impulses to each side to accustomise participant to the procedure 
9. A minimum of 10 Head Impulses was then performed to each side in 
pseudo-randomized order using roman number tables.  Impulses were at 
a minimum of 150°/s 
a. EzeEye Software measured head velocity and eye velocity allowing 
for calculation of gain.  
10. Break 10 minutes 
11. Participants were then instructed to lie down on the examination bed, 
with the head angled at 30 degrees, for the caloric procedure 
12. The EyeSeeCam was mounted on a pair of goggles, with opaque lenses to 
avoid visual fixation, and these were placed on the participant 
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13. With the lens was removed the EyeSeeCam was calibrated. The opaque 
lens was then replaced.  
14. Calorics using the Fitzgerald and Hallpike technique were then performed 
with at least seven minutes break between each irrigation in order to 
avoid additive effects.   
a. Caloric information was recorded by EzeEye software using the 
EyeSeeCam.  LC, RC, RW, LW, nystagmus was used to calculation 
canal paresis using the Jongkees formula 
15. Thank participant  
 
3.6.2 Test Two  
 
Standard Examination Procedure: 
1. Open participants pass word protected file 
2. Cognitive function testing using CANTAB cognition battery 
a. Big Little Circle 
b. Motor Screening Test 
c. Paired Associated Learning 
d. Intra/Extra Dimensional Shift 
3. DHI questionnaire  
4. Seat participant 1.5m from target  
5. Mount goggles on the patient, align camera  
6. Calibrate EyeSeeCam 
7. 3 Head impulses to each side to customize participant to the procedure 
8. A minimum of 10 Head Impulses was then performed to each side in 
pseudo-randomized order using roman number tables.  Impulses were at 
a minimum of 150°/s 
a. EzeEye Software measured head velocity and eye velocity allowing 
for calculation of gain.  
9. Break 10 minutes 
10. Participants were then instructed to lie down on the examination bed, 
with the head angled at 30 degrees for the caloric procedure 
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11. The EyeSeeCam was mounted on a pair of goggles with opaque lenses to 
avoid visual fixation, and these were placed on the participant 
12. The lens was removed and EyeSeeCam was calibrated.   
13. Calorics using the Fitzgerald and Hallpike technique were then performed 
with at least seven minutes break between each irrigation in order to 
avoid additive effects.   
a. Caloric information was recorded by EzeEye software using the 
EyeSeeCam.  LC, RC, RW, LW, nystagmus was used to calculation 
canal paresis using the Jongkees formula 
14. Thank participant  
 
At the second testing audiometry was not performed due to resource limitations. 
Cognitive testing using the CANTAB battery was performed to evaluate cognitive 
function in the context of a stable vestibular lesion..   
 
3.7 Outcome Measures 
 
Primary outcome measures were gain on vHIT at a rotational velocity of above 
150 degrees/second, and degree of canal paresis as a consequence of caloric 
stimulation.  These measures were compared to determine sensitivity of vHIT 
versus the traditional clinical gold standard of caloric testing. 
 
Secondary outcome measures included DHI score, audiometry, tumor size and 
cognitive measures.  These were taken in order to elucidate the relationship 
between vestibular function tests, tumor size and patient impact.  
 
3.7.1 Preliminary Data Inspection  
 
Statistical analysis was performed in SPPS version 17 and p<0.05 was 
considered significant.  Descriptive statistics were generated, including means 
and standard deviations, to scrutinize the data for overt anomalies and general 
trends.  Following this Sharpiro-Wilk tests were performed to ascertain where 
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the data followed a normal distribution.    It was held that where data had 
abnormal distribution central limit theorem would provide some protection 
against the violation of the assumption of normality (226, 227) Two-Tailed T-
Tests were performed to compare for difference in bilateral measures, i.e. gain, 
and peak slow phase velocity, p<0.05 was considered significant. To consider 
that VS vestibular schwannoma results in a significant change in vestibular 
function p<0.05 was considered significant.  
 
Exploratory factor analysis was performed to identify relationships between the 
data in a non-biased manner.  Specific relationships were then probed using 
Pearson’s correlation coefficients. 
 
3.7.2 Secondary Data Analysis  
 
Linear regression analysis was performed to identify the degree to which canal 
paresis could be predicted from other variables as well as further validating the 
correlational analysis.  If two predictor variables have a correlation higher than 
0.9 multicolinearality is indicated, this would call into question the validity of the 
multiple regression analysis.  Sensitivity and specificity were calculated to 








4.1 Demographics  
 
Thirty-two subjects with unilateral VS consented to participate.  One subject was 
excluded, due to congenital nystagmus.  The final number enrolled and included in the 
analysis was 31, 13 women, mean age at testing was 62 years (34 to 81 years).  For 18 
participants the tumours were right sided and for 13 tumours were left sided.  Of the 31 
participants 8 had undergone radiotherapy and 23 had followed ‘wait and watch’.  
 
Repeat testing 6 months after initial testing was possible and completed for 10 of the 30 
participants (n=10, 5 female, mean age at repeat testing 63.9 years (Range 51 to 81 
years).  All of who were included in the statistical analysis.  
 
No negative outcomes occurred throughout the testing, and no participant suffered an 
adverse event.   
 




Caloric testing was performed in all 31 participants (Figure 9); follow-up testing was 
performed in 10 participants. Shapiro-Wilk tests of normality on all caloric results showed 
that caloric canal paresis followed a non-normal distribution, D (31) = 0.915, p = 0.020 
(Table 5).    
 
The mean canal paresis by Jongkees formula was 0.39 (SD = 0.30). This asymmetry was 
reflected in peak slow phase nystagmus velocities achieved in both cool and warm 
irrigations, consistent with technically adequate irrigations and VOG recording:  Cool 30qC 
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irrigations resulted in reduced response on the tumour side  (M= 5.74q/s, SD=4.71) 
compared to the healthy side (10.6q/s, SD=7.78), t (30)= -4.95, p <.001, r= 0.45; warm  
44qC irrigations resulted in a reduced response on the tumour side (8.23q/s, SD=8.98) 
compared to warm water irrigation on the non-tumour side (17.54q/s, SD=11.68), t 
(30)= -5.34, p < .001, r=0.49.   
 
For the 10 participants who underwent repeat testing, the 6-month interval canal paresis 
was 0.41 (SD = 0.28).   Repeat canal paresis following the first testing (0.39, SD=0. 21) 
was not significantly different to Canal Paresis at the second testing, t test1 (0. 41, SD=0. 
28), t (9)=0. 99, p=0. 35 
 
4.2.2 Head Impulse Test  
 
Quantitative VOG head impulse testing was performed in all 31 participants (Figure 10).   
 
The ipsilesional vHIT gain, D (30) = 0.84, p < 0.001, the contralesional vHIT gain, D 
(30)=0.92, p = 0.033 and the gain asymmetry D (30) = 0.86, p<=0.001, were all 
significantly non-normal (Table 5).    
 
At the first testing (n=31) mean gain (eye angular velocity divided by head angular 
velocity at 60ms after initiation of head movement) on the tumour side was 0.73 (SD= 
0.31).  Mean gain on the healthy side was 0.90 (SD=0.12), which was different by t test1 
(t (30) = -3.94, p<0.001, r=0. 34.    
 
Converting these to a mean gain asymmetry, by Jongkees formula, was 0.14 (SD = 0.27).  
 
Repeat HIT was performed in the 10 participants who underwent a second 6-month 
assessment.  At the second measure mean gain on tumour side was 0.87 (SD = 0.25).  
Mean gain on the contralateral non-lessoned side was 0.98 (SD=0.09).  Mean gain 
asymmetry was 0.04 (SD = 0.18).    
                                                        
1. See methods page 64 for justification of using T-Test 
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In the sub group where repeat testing was performed, there was no significant difference 
between gain asymmetry following the first testing (0.07, SD=0. 15) than gain asymmetry 
at the second testing (0. 04, SD=0. 18), t (9)=-0.926, p=0. 38).  This was also found for 
ipsilesional gain t(9) = -0.661, p=0.525 
 
4.2.3 Sensitivity and Specificity of vHIT to Caloric Canal Paresis.    
 
HIT sensitivity using a threshold of gain <0.74, sensitivity was 42%, specificity was 90%.   
When a gain threshold of <0.92 was used sensitivity was 80% and the specificity was 










































Figure 9: Caloric Irrigation Trace 
Figure 9 Table: The irrigation shows strong left sided response to caloric irrigation and almost no 
response to right sided irrigation indicating a high level of canal paresis. 
Red: Warm Irrigation, Blue: Cool Irrigation 
 
X Axis – Time in Seconds,  


































Shapiro Wilk  Statistic  df Sig 
Caloric Canal Paresis 
 0.91 30 0.02 
Ipsilesional vHIT Gain  0.86 30 0.001 
Contralesional vHIT Gain 0.92 30 0.033 
Asymmetry of Gain 0.86 30 0.001 
DHI 0.91 30 0.018 
Table 5: Legend:  The null-hypothesis states that the data comes from a 
normal population, significant result indicates that the null hypothesis is 






Table 5: Tests of Normality 
Figure 10: Head Impulse Test Traces 
Figure 10 Legend: The left trace shows normal vestibular 
ocular reflex function.  The right trace shows depressed 
vestibular ocular reflex function 
Red: Head Movement , Blue Eye Movement 
 
X-Axis: Time in MS 






































0-25 % 10 1 9 3 7 3 7 
25-50 % 10 1 9 7 3 7 3 
50-75 % 6 3 3 5 1 5 1 






Table 6: Sensitivity and Specificity of Head Impulse Testing in Comparison to Calorics 
Table 6 Legend: The total shows the number of positive and negative head impulse tests classified accordingly to 
severity of canal paresis 
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4.3 Tumour Size 
Tumours were measured on radiology measuring stations using submillitmeter digitals 
rulers.  Of the 31 tumours, 14 were intracannalicular and 17 were extracannalicular as 
determined by MRI observation, CT scans and participant notes.  Three could not be 
measured, as due to administrative reasons the MRI scans were not available due to 
administrative reasons.     
 
Of the extracannalicular tumours the measurements made in the cerebellopontine angle 
showed the mean transverse length was 12.69mm (SD=58.9), the mean anteroposterior 
was 8.53mm (SD=58.7), and the mean longitudinal dimension was 7.65mm (SD = 46.9). 
Seven tumours were classified as small, seven medium, one moderately large and there 
were no large or giant tumours Three could not be classified as measurement could not be 
performed due to unavailable MRI scans.  
 
For intracannalicular tumours the mean length along the internal auditory canal for 
intracannalicular tumours was 86.8mm (SD=28.0).  
 
4.4 Dizziness Handicap Inventory  
 
Mean DHI score among participants was 19.30 (SD=17.34) (Figure 11).  At follow up 
testing in 10 participants the mean DHI was 15 (SD=13.67) 
 
The mean DHI score at first testing (14, SD=14.757) was not significantly different from 











































Figure 11 Legend The box shows interquartile range and  the 
median score.  Whiskers represent the minimum and maximum 
DHI scores 
 
Figure 11: Dizziness Handicap Inventory Distribution  
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4.5 Audiometry  
 
Pure tone audiometry was performed in 10 participants (Table 7).   Mean pure tone 
average on the ipsilesional side was 70.5 (SD=29.8).  Mean pure tone on the 
contralesional side was 24.0  (SD = 9.71). 
 
The PTA on the ipsilesional side (M=70.5, SD=29.8) was significantly greater than the 



































Table 7: Pure Tone Audiometry Thresholds At Standard Frequencies  




10 10.00 35.00 18.50 9.73 
Non Tumour 1kHz 
 10 15.00 35.00 21.50 6.26 
Non Tumour 2kHz 




10 15.00 70.00 35.50 20.07 
Tumour 0.5kHz 
 10 15.00 110.00 53.50 31.71 
Tumour 1kHz 
 10 15.00 120.00 67.50 32.94 
Tumour 2kHz 
 10 30.00 120.00 77.00 31.90 
Tumour 4kHz 10 45.00 120.00 84.00 27.26 
      






Table 8: Summary of Key Vestibular Function Measures 
 N Minimum Maximu
m 
Mean Std. Deviation 
     
Caloric Canal Paresis, ratio 0-1 31 0.99 0.01 0.39 0.30 
Ipsilesional vHIT Gain on; ratio 0-1 31 0.05 1.05 0.72 0.31 
Contralesional vHIT gain; ratio 0-1 31 0.59 1.07 0.90 0.12 
Gain Asymmetry ; ratio 0-1 31 0.84 0.47 0.14 0.27 
Pure Tone Audiometry on Tumour Side (dbHL) 10 26.25 117.50 70.50 29.79 
Pure Tone Audiometry on Non-Tumour Side (dbHL) 10 15.00 43.75 24.00 9.71 
Dizziness Handicap Inventory (Score of 100) 31 0.00 63.00 19.30 17.34 
Peak Slow Phase Velocity of Nystagmus following cool 
irrigation on tumour side °/s 
31 0.00 16.65 5.74 4.71 
Peak Slow Phase Velocity of Nystagmus following warm 
irrigation on tumour side, °/s 
31 0.00 33.98 8.22 8.98 
Peak Slow Phase Velocity of Nystagmus following cool 
irrigation on non tumour side, °/s 
31 1.03 35.52 10.63 7.78 
Peak Slow Phase Velocity of Nystagmus following warm 
irrigation on non tumour side, °/s 
31 0.80 48.69 17.54 11.68 
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4.6 Comparative Statistical Analysis  
 
4.6.1Factor Analysis  
 
Exploratory Independent Factor Analysis was performed for ten items with 
orthogonal rotation (Promax) to elucidate relationships between the test 
variables.  The Kaiser-Mayer-Olkin measure verified the sampling accuracy for 
the measure, KMO=0.75.  Bartlett’s	test	of	sphericity	(Chi Squared (28)=170.95, p 
<001), indicated that correlations between items were sufficiently large for 
factor analysis.  An initial analysis was run to obtain eigen values for each 
component in the data.  Two components had eigen values greater than one, and 
in combination explained 75.6% of the variance.  Given the sample size and the 
scree plot convergence 2 components were retained in the final analysis as they 
accounted for the majority of the variance (Table 9). The items that cluster on 
component 1 suggest component 1 represents the degree of vestibular 
impairment.  Items that cluster on component 2 suggest that it represents a 
degree of functional impairment, i.e. DHI.  
 
Significant loading was seen in between tumour dimensions and the vestibular 
function measures of both caloric testing and HIT.  
 
4.6.2 Pairwise Correlations 
 
Items that showed significantly clustering on a single factor were further 
investigated	 with	 pairwise	 correlations	 using	 Pearson’s	 correlation	 coefficient 
(Table 10). Significant results were found for Canal Paresis/ Ipsilesional Gain 







































Transverse Dimension -0.89 0.07 
Longitudinal Dimension -0.87 0.23 
Ipsilesional vHIT Gain  0.85 0.30 
Caloric Canal Paresis 0.83 0.02 
Asymmetry of Gain 0.82 0.12 
Anteroposterior Dimension -0.77 0.37 
Contralesional vHIT gain  0.77 0.44 
Dizziness Handicap Inventory -0.18 0.84 
Independent Factor Analysis 
 
Table 9: Factor Analysis Component Matrix:   
Table 9 Legend: Degree of component loading indicates the closeness in 










Table 10 Legend:  Pearson’s	Correlation	Coefficients.		Strength	of	correlation	is	
graded between 0-1, with one indicating perfect positive correlation. 
 
Correlated Pair r-score Significance level p(two-
tailed) 








Ipsilesional vHIT Gain vs 
Audiometry 
r=-0.30 p=0.35 


















Table 10: Pearson’s	Pairwise	Correlations	 
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4.7 Modeling Canal Paresis 
 
No variables showed a Pearson correlation coefficient above 0.9. This indicates 
there is no multicollinearity, and therefore multiple regressions are a valid 
comparative statistical methodology.   
 
Multiple regression analysis was used to test how well the vestibular battery, 
including HIT and DHI, predicted canal Paresis.  Results indicated that creating a 
model for canal paresis utilizing other measures of vestibular function explained 
73.9% of the variance (R=0. 894, F (6,26)=13.274, p<. 001) (Table 11,12).  It 
was found that ipsilesional vHIT gain predicted canal paresis (β=0.	 721,	 p<.	








Model R R Square Adjusted R Square Std. Error of the Estimate 
1 0.894a 0.8 .74 6.16 
a. Predictors: (Constant), Longitudinal Dimension, Dizziness Handicap Inventory, Contralesional vHIT gain , 
Ipselesional vHIT Gain, Transverse Dimension, Anteroposterior Dimension 
 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 1.97 6 0.33 13.27 0.000b 
Residual 0.493 20 0.025 
  
Total 2.46 26 
   
a. Dependent Variable: Caloric Canal Paresis 
b. Predictors: (Constant), Longitudinal Dimension, Jacobsen Dizziness Inventory, Contralesional vHIT gain, Ipsilesional vHIT Gain, 
Transverse Dimension, Anteroposterior Dimension 
Table 11:  Multiple Regression Analysis Model Summary 
Table 11 Legend Adjusted R Square value indicates modeling canal paresis using alternative vestibular battery 
measures accounts for .739 of the variance. 
 
Table 12:  Multiple Regression Analysis ANOVA 








Model Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
1 
(Constant) -1.07 0.39 
 
-2.75 0.012 
Ipsilesional vHIT Gain 0.70 0.17 0.72 4.20 0.000 
Contralesional vHIT gain  0.30 0.46 0.12 0.66 0.52 
Dizziness Handicap Inventory -0.005 0.002 -0.26 -2.36 0.03 
Transverse Dimension 0.007 0.011 0.13 0.59 0.56 
Anteroposterior Dimension -0.002 0.012 -0.04 -0.17 0.87 
Logtitudinal Dimension -0.009 0.02 -0.14 -0.47 0.65 








Table 13: Multiple Regression Analysis Coefficients   
 
Table 13 Legend:  Model indicates ipsilesional vHIT gain and DHI are significant predictors of canal paresis.  With 
ipsilesional vHIT gain accounting for the majority of the variance. 
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4.8 Modeling Canal Paresis using vHIT Gain 
 
Linear regression analysis was performed on a subset of the data to investigate 
the robustness of the model. Specifically, this was used to see if ipsilesional vHIT 
gain was predictive of canal paresis.  A good predictive model would indicate 
that there is a strong relationship between the ipsilesional gain, PTA test results 
and	the	participants’	canal	paresis.		 
 
 Results showed that 68% of the variance could be explained (R=0.831, F 
(7,9)=64.67, p<0.001 (Table 14,15).   It was found that ipsilesional vHIT gain 








































Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 0.83a 0.69 0.68 0.168 
a. Predictors: (Constant), Ipsilesional vHIT Gain  
 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 1.82 1 1.819 64.69 0.000b 
Residual 0.82 29 0.028   
Total 2.64 30    
a. Dependent Variable: Caloric Canal Paresis 
b. Predictors: (Constant), Ipsilesional vHIT Gain  
Table 14:  Linear Regression Analysis Model Summary 
Table 14: Legend: Adjusted R Square indicates modeling canal paresis using HIT gain accounts for 




Table 15 Legend:  ANOVA testing the variation showed in the model is significant 
 
 














Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 
(Constant) -0.98 0.079  -12.42 0.000   
Ipsilesional Gain 0.804 0.10 0.831 8.04 0.000 1.000 1.000 
a. Dependent Variable: Caloric Canal Paresis 
Table 16:  Linear Regression Analysis Coefficients  
Table 16 Legend: The model indicates that Ipsilesional gain accounts for 0.831 of the 




4.9 Cognitive Function  
 
Cognitive Function was assessed in ten participants (Table 17).  Mean Intra-
extradimensional shift adjusted error in the vestibular schwannoma group 
(M=21.6, SD=17.81) was significantly more than mean Intra-extradimensional 
shift adjusted error in normals from the published literature (M=4.40 SD=6.13), 
t(59)=5.55,p=.001. 
 
Mean paired associates learning Total Error Adjusted in the vestibular 
schwannoma group (M=32.4, SD=36.03) was significantly more than the mean 
paired associates learning total error adjusted in normals from the published 
literature (M=19.58, SD=14.33), t(59)=3.40, p=0.001 
 
Further multiple regression analysis was	 performed	 on	 the	 participant’s	
cognitive percentiles to investigate the robustness of the model.  Multiple 
analyses revealed no significant effects.   However, specifically looking to see if 
canal paresis could be predicted from Intra extra dimensional shift.     Regression 
analysis found 77.5% of the variance could be explained (R=0.92, 
F(5,2)=13.03, p=.01 (Table 18,19) .   It was found that Intra-extra dimensional 


























Test Performed N Minimum Maximum Mean Std. Deviation 
Big Little Circle Percent Correct 








10 7.00 9.00 8.80 0.63 
Motor Screening Task Mean 
Latency, ms 
 
10 709.3 1396.00 949.86 244.43 
Motor Screening Task Mean 
Error 
 
10 6.61 26.10 10.85 5.62 
Paired Associates Learning 
Total Error Adjusted 
 
10 3.00 115.0 32.40 36.03 
Paired Associates Learning  
Total Errors 6 shapes adjusted 10 0.00 45.00 12.60 14.14 
Valid N (listwise) 10     
Table 17: CANTAB Cognitive Measures Summary 
Table 17 Legend: CANTAB Test Results Included both total number of errors 








Model R R Square Adjusted R 
Square 




      











Regression 0.328 2 0.164 13.03 0.010 
Residual 0.063 5 0.013   
Total     0.390                     7    
 
      
      
      
 
Table 18: Cognitive Linear Regression Analysis Model Summary  
 
Table 19: Cognitive Linear Regression Analysis ANOVA  
 
Table 18 Legend:  Modeling canal paresis using Intra-Extradimensional Shift total error 
accounts for 0.459 of the variance 
 






































t Sig. Collinearity 
Statistics 








-0.008 0.003 -0.73 -2.63 0.039 1.000 1.000 
 
(Constant)        
 -.       
 -  -     
 
 
Table 20: Cognitive Linear Regression Analysis Coefficients  
 
Table 20 Legend: The model indicates that Intra-Extradimensional Shift total 
error accounts for 73% of the variance found in the model 
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4.10 Summary of Key Results  
 
1. Subjects who declined to participate in this study most commonly 
volunteered apprehension regarding caloric irrigations, potentially 
supporting the rationale of this study.  
2. Exploratory independent component analysis shows caloric canal paresis, 
vHIT gain, and tumour sizes all clustered on the same factor    
3. Video-HIT ipsilesional gain correlates with degree of canal paresis  
4. A valid linear regression model uses HIT ipsilesional gain to predict 
caloric canal paresis.    
5. Setting a threshold of vHIT gain to <0.92 gave a sensitivity of 80% for 
vHIT in comparison to caloric testing (25% canal paresis threshold for 
abnormal).      
6. Symptom score, the DHI did not correlate with vestibular reflex function, 
as is the case in other vestibular disorders. 
7. Repeat testing of 10 subjects revealed stable vestibular function over six 
months.   Specific cognitive domains in the CANTAB Cognitive battery 















Caloric testing has formed the backbone of quantitative vestibular analysis for 
over a hundred years.  Though effective in identifying vestibular hypo function, it 
has been likened to testing hearing with thunder, and vision with lightning.  
Caloric testing can also induce a significant level of patient discomfort.  While the 
equipment required means that testing is often restricted to specialized 
vestibular centers.  More widespread use of vestibular function testing could 
result in better diagnosis and management of vestibular dysfunction.    
Unfortunately, newer testing modalities have consistently failed to reach 
comparable levels of accuracy.  Validation of a new quicker testing method with 
less patient discomfort could lead to widespread adoption of quantitative 
vestibular testing. A consequence of better quantification of vestibular 
dysfunction, being improved management of the patients overall condition.     
 
The study contained in this thesis tested the hypothesis that head impulse 
testing using video oculography is comparable to caloric testing as a measure of 
vestibular function in patients with unilateral vestibular schwannoma.  Head 
impulse testing with video-oculography has been shown in one study to have 
comparable levels of accuracy to caloric testing(132).  The testing process has 
few exclusion criteria, and causes less discomfort than calorics. It also assesses 
vestibular capacity in the normal range of function.  Validation of this 
methodology could lead to wider testing of vestibular function and better 
management of patients.  
 
5.1 Participant Demographics 
 
Mean age was 62 years, this is similar to the one New Zealand case series of 97 
vestibular schwannoma patients, with an average age of 54 years, the male to 
female ratio is also similar(228). Both studies are comparable to a systematic 
review highlighting the mean patient age 62 (range 52-75) years, with 
comparative gender splits(74).  These results suggest a degree of external 
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validity, indicating that comparisons between similar studies can be made.  
While differences between this and other studies are unlikely to be due to age 
related effects.  
 
It is interesting to note that of those that declined to participate, five did so due 
to volunteered apprehension about tolerating caloric testing. In contrast no 
participants volunteered apprehension about undergoing vHIT.  This indicates 
that caloric testing is perceived as a distressing experience, underlying the 
importance of this study in validating alternative methods of vestibular function 
testing.  
 
5.2 Sensitivity and Specificity of Head Impulse 
testing 
 
Both vHIT gain using a cut off of 0.94 and gain asymmetry calculated by 
comparing the difference between left and right-sided gain, similar to the 
Jongkees formula show more promise than simple analysis of gain values if the 
gain is set at 0.74. There is limited data on normal gain values. The use of 0.74 
was based on a publication that  reported  gain two standard deviations (SD) 
below the mean as the lower cut off for normal(123).  Given the size of this study, 
using this value as the cut-off for abnormal gain is somewhat questionable.   The 
authors analysis assumes that the data is normally distributed.   For sample sizes 
smaller than 30 (n=24), this assumption may not be true. Further highlighting 
this point the Shapiro-Wilk test of normality on the gain data (n=31) reported in 
this thesis found it did not follow a normal distribution.   Given it is likely that 
gain values are not normally distributed assuming normal gains fall within 2 SD 




To increase the sensitivity of the vHIT a lower threshold of 0.92 was also 
considered.  Given the lower threshold it is likely that increased vestibular 
dysfunction will be identified, if the corresponding specificity is still high 
however this may be acceptable.  The use of gain asymmetry to identify 
vestibular function is a novel with only one of the few studies exploring gain 
asymmetry considering asymmetry  greater than 5.6%  as pathological.  Given 
this method is more analgous to l Jongkees formula for assessing caloric 
asymmetry, it is surprising that its use has not found greater scope.  To further 
investigate this a gain assymetry value of 5.6% was utilized in this study when 
considering pathological gain asymmetry (123), this was then compared to raw 
gain, the value more commonly used.  In comparison to caloric, vHIT shows a 
sensitivity of 42%, and a specificity of 90%, using an asymmetry  cut off of 0.74, 
higher than published results using HIT without video oculography(111, 128).  
However, when a gain value of <0.92 is taken to be pathological the sensitivity 
increase to 80% while the specificity decreases to 70%.  The same sensitivity and 
specificity is found by using gain asymmetry to assess pathology.   Using a gain 
value of 0.92 as the cut off sensitivity is comparable to oVEMP, which shows 
sensitivity ranging between 61.5%-80% and much lower specificity at 50%(148, 
152, 156, 159).  It is also more consistently superior to cVEMP, which shows a 
sensitivity ranging between 37.5%-69%(148, 152, 156).  
The increase in sensitivity when comparing canal paresis and vHIT gain 
asymmetry is likely due to the nature of the measures. With calorics absolute 
slow phase nystagmus values are used to measure vestibular function; due to 
their wide normal range, between 5-67 °/s, the slow phase values from all four 
irrigations are then converted into a canal paresis ratio.  Though more restricted, 
it is possible that HIT gain follows this same pattern, with a normal gain ranging 
between 0.74-0.96.  Vestibular ocular reflex gain asymmetry therefore provides 
a more analogous comparison to canal paresis, where it is the response 
difference between the sides that is held to be clinically significant.   
Alternatively the increased sensitivity found by decreasing the cut off for 
abnormal gain to 0.92 may be due to up-regulation of the cervico-ocular reflex 
necessitating this less strict criterion. Cervico-ocular responses are greatly 
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increased in both individuals and primates with diminished vestibular ocular 
response(24, 229-231).  It is possible that HIT activates the cervico–ocular reflex 
via neck proprioceptors.   This could then result a compensatory increase in gain, 
particularly in vestibular compensated individuals. Other visual gaze 
stabilization pathways, such as smooth pursuit, are unlikely to impact on HIT 
recording given they operate at much lower frequencies.  If this were the case a 
lower cut off for pathological gain (i.e. 0.92) would result in greater sensitivity of 
testing, as in found in the results of this thesis.    
 
Both vHIT gain and vHIT gain asymmetry mirrored calorics canal paresis.  Gain 
towards the side of lesion showed a strong, statistically significant negative 
correlation with canal paresis, i.e. as gain deceases canal paresis increases.   This 
effect remained when canal paresis was correlated with gain asymmetry, though 
the relationship was weaker.   Further testing using multiple regressions using 
vestibular measures to model canal paresis showed a highly significant model 
accounting for 74% of the variance.  Of the predictive factors, only two were 
significant, ipsilesional vHIT gain and DHI.  However any change to vHIT was 
mirrored very closely by changes in canal paresis, as vHIT accounted for the 
majority of the variance.  A single regression analysis,  modeling gain asymmetry 
was again highly significant with vHIT accounting for the majority of the 
variance in calorics.    The differences between the statistical models are likely to 
have arisen from the nature of the tests themselves.   Caloric testing stimulates 
vestibular response through convection currents, volume displacement and 
direct temperature effects.  This is equivalent to a rotational frequency between 
0.002-0.005 Hz. With vHIT examiner driven head rotation to one side induces 
endolymph movement, which deforms the cupulae of both lateral semicircular 
canals.  This induces both a contralateral inhibitory and an ipsilateral excitatory 
response along the vestibular nerve to the vestibular nuclei. In patients with a 
unilateral deficit, the diminished response from the ipsilesional side and 
saturation of the contralesional inhibitory response leads to a failure of the VOR 
and a catch-up saccade. This occurs at frequencies of between 4 to 6 Hz and is 
therefore more representative of day-to-day head movement. It should be 
recognized that each test is stimulating the vestibular system at a different 
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frequency; consequently it is possible that the difference between the two 
measures is due to underlying differences in the afferent conduction pathways or 
how these responses are interpreted in the vestibular nuclei.  Alternately a 
combination of both may play a role.  No literature could be found detailing how 
different stimulation frequencies effect the processing of vestibular input.  
Regardless of this difference the degree to which gain and gain asymmetry 
mirrored variance in canal paresis implies that they are appropriate analogues.  
It is also worth considering that vestibular function is known to deteriorate with 
age, deterioration affects both right and left sides similarly(232). Therefore, a 
unilateral measure of vestibular function could give the impression of a one 
sided vestibular deficit if significant age related deterioration has occurred (i.e. a 
false positive result).  However, by comparing sides, which are likely to have 
experienced equal deterioration, one removes this problem.  
Both calorics and vHIT assess the VOR primarily by stimulating the lateral 
semicircular canal;  which is innervated by the superior division of the 
vestibulocochlear nerve . Initially it was believed that most VS arise from the 
superior aspect of the vestibulocochlear nerve(233),  more recently it has been 
suggested that this is not so(234). With several authors reporting a much higher 
frequency of inferior VS to superior VS (235-237).  Under reporting of inferior VS 
may because they cannot be classified as readily(236). Therefore if the VS is 
impinging on the inferior vestibular nerve function and reducing its function, but 
not superior nerve function then both vHIT and calorics testing may fail to 
accurately assess vestibular function.  This would provide some explanation as 
to why both tests did not produce abnormal responses for all VS.   It is therefore 
advisable when monitoring vestibular function in VS that a measure of the 
inferior vestibular nerve function, i.e. cVEMP, be used.  
 
The relatively high sensitivity of head impulse testing using a cut off of 0.92 and 
gain asymmetry as well as the degree to which a change in vHIT results are 
mirrored by a change in canal paresis indicates that video head impulse testing 
using video oculography is a promising alternative to caloric testing, though 
further research is needed.   
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5.3 Audiometry  
Audiometry results showed significant hearing impairment on the side of the 
tumour.  This is consistent with the well-established body of literature 
highlighting hearing loss in 95% of patients with VS (238).  It is worth noting 
that only 10 pure tone audiometry tests and no speech discrimination scores 
could be assessed due to resource limitations. Pure tone audiometry showed a 
positive correlation with anteroposterior tumour and vertical tumour 
dimension.  However, it showed no correlation with DHI or other vestibular 
function measures.  The correlation of audiometry and tumour size could suggest 
that the dysfunction is due to tumour mass effects, either physical interruption of 
the blood supply or of the nerve conduction pathway.  This is consistent with the 
mechanism of injury highlighted in the literature, given that this is the same 
proposed mechanism for vestibular dysfunction it is interesting that they did not 
correlate(22, 187).   The difference may be due to vestibular compensation 
without hearing compensation.  Perhaps highlighting that the auditory fibers of 
the vestibulocochlear nerve are more sensitive to schwannoma growth.  
 
Furthermore tumour size is a known predictive factor for postoperative hearing 
loss(239, 240). Given that hearing will deteriorate regardless of tumour growth, 
degree of hearing preservation is a key consideration when selecting the wait 
and watch approach over surgery.  Consequently hearing preservation must be 
taken into account in patient management.  
 
 
5.4 Dizziness Handicap Inventory 
 
The degree to which balance dysfunction can result in health related morbidity 
means that the impact of VS on balance is important.  Indeed given the impact of 
balance function on quality of life it is surprising that it is not frequently 
measured in VS more often.  The DHI scores were comparable with results 
published in the literature, indicating that there is a consistent level of 
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dysfunction with VS(163, 164).  No vestibular or hearing function parameter was 
found to correlate with the DHI score.  This is likely due to the capacity of the 
vestibular system to functionally compensate.  Vestibular schwannoma is a slow 
growing, sometimes-stable unilateral vestibular lesion; this allows the vestibular 
system to compensate over time.  While the up regulation of the visual and other 
systems may also play a contributing role(44, 241).  It is possible that in the 
context of a rapidly growing VS the balance system would not be able to 
compensate and a greater degree of vestibular dysfunction would be realized.  If 
this were the case serial DHI assessment could be used to monitor for tumour 
growth; with significant increase in DHI score an indicator for failure of 
conservative treatment and earlier MRI scanning.  
 
5.5 Tumour size  
 
Tumour size is an important factor in presurgical decision-making, given that 
tumour size at surgery is predictive of postoperative hearing loss, and facial 
nerve function(170, 171).  In this study VS sizes were consistent with the 
published literature(76, 77).  Tumour size showed a strong positive correlation 
with vestibular function measures, this is consistent with the proposed 
mechanisms of dysfunction and the published literature; while highlighting that 
though functional compensation may occur both gain and canal paresis do not 
return to pre lesion levels (22).  Perhaps the most useful measure is rate of 
tumour growth.  Relating tumour growth to changing vestibular function 
measures could allow for better presurgical decision making. Such as using 
vestibular testing to predict patients who are likely to have more post-op vertigo 
and who will benefit most from postoperative vestibular rehabilitation. 
Unfortunately this could not be performed due to the short time frame of the 






5.6 Cognitive Testing  
 
The CANTAB results indicated that VS impacts upon cognitive function to some 
degree.  Cognitive testing indicated participants were in the lower percentiles of 
function.  Which was particularly marked for Intra-Extra Dimensional shift. This 
is consistent with linear regression model that indicated that Intra-Extra 
Dimensional Shift results are a significant predictive factor for caloric canal 
paresis.  The significantly higher number of errors in Paired Associates Learning 
and Intra-Extra Dimensional Shift seen among the participants are consistent 
with the literature highlighting the vestibular basis for some cognitive deficits.   
These underlying cognitive deficits may explain some of the associated 
psychiatric issues seen in patients with vestibular lesions(242, 243).  Better 
assessment of this aspect of vestibular dysfunction could lead to more effective 
interventions and better patient outcomes.   These results while highlighting that 
cognitive testing may have a role to play in vestibular function testing and 
treatment, suggest that further study with a larger sample size is indicated.  
 
6. Limitations and Further Work  
 
One source of concern throughout this study was a acquiring a large enough 
sample to have sufficient power to be able to draw valid conclusions. Throughout 
the study attention was paid to this by contacting those living the greater Otago 
Southland area and not limiting recruitment to those in the Dunedin 
metropolitan area.  Regardless, conclusions drawn here about repeated 
measures have to be interpreted cautiously due to the small sample size.  This 
was largely due to the time frame limitations imposed by the short duration of 
the research period (1year).  Audiometry testing was poor, both in terms of final 
numbers and breadth of testing modalities 
  
Further work is needed following up the remainder of the cohort, to show the 
repeatability of the data collected and allow a fuller picture of cognitive function. 
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This thesis examined only two measures of vestibular function, calorics and 
vHIT, but excluded other methods such as VEMPs.  Vestibular evoked myogenic 
potentials are an increasingly relevant method of investigation vestibular 
function.  Inclusion in this study would not only have allowed investigating the 
relative sensitivities of each method but how they work in conjunction with one 
another.  Considering the anatomical arrangement of the vestibular nerve it is 
perhaps the use of these different testing methodologies in conjunction with one 
another that would be most useful.  A long-term prospective cohort study with 
serial MRI scanning could then relate degree of tumour growth to vestibular 
function test results and recurrent DHI assessment.  This would allow for the 
development of a standardized vestibular testing battery.  To validate this 
further observational studies investigating the range of normal HIT gains in the 
general population are needed, as well as further longitudinal observational of 
clinical cohorts such as this.  
 
Other possible measures of vestibular function available when performing vHIT 
include observation of catch-up saccades (overt and covert) and 3D vector 
analysis.  A 3D analysis of rotational eye movements was not performed due to 
lack of expertise.  This would have ensured rotation was only in the horizontal 
plane activating only the horizontal semicircular canals.  Observation of saccades 
is the traditional measure a positive head impulse test.  As the goal of the study 
was to identify quantifiable measures of gain values this analysis was not 
performed.  However, frequency of covert saccades would have added to the 
research by highlighting the lack of sensitivity of qualitative head impulse 
testing. This would further justify the use of video-oculographic equipment.  
 
 
The use of the participants as their own controls limited the degree to which the 
cognitive data could be interpreted.  Reliance on already published data means 
that there is poor matching between subjects and controls.  This increases the 
likelihood of confounding and spurious results.  Indeed in this study it is possible 
that the marked difference seen in the Intra-Extra Dimensional shift and Paired 
Associates Learning errors is due to age related confounding, given that there 
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was a large age difference between the group tested and the normal values 
comparison taken from the literature and used for.  More definitive studies on 
vestibular cognition and its relationship with vestibular function measures and 
functional outcomes are needed.   With a larger sample size and properly 
matched control group being the key factors.    
 
7. Conclusion  
 
Video HIT is a promising alternative to caloric testing for measuring vestibular 
function in VS as it shows good correlation with, and sensitivity to, the standard 
caloric testing as seen in this cohort.  With qualitative feedback indicating it is a 
more acceptable test.  Further study is needed to validate the selection of 0.92 as 
the cut off for abnormal gain.  
 
Given that vHIT operates at a frequency range that is closer to everyday function 
it may better reflect vestibular disturbance than calorics, however this has not 
been shown in this, or other studies. Further prospective observation is required 
to determine if changes in HIT reflect changes in tumour growth, and if this may 
be as an important factor when considering outcome following either surgery of 
radiotherapy.  
 
Although hearing function deteriorates regardless of proven tumor growth, 
audiometric monitoring is an important part of current management additional 
to MRI.      
 
Vestibular function is similarly important yet is relatively neglected in the 
clinical setting.   The availability and degree of validation of a relatively new 
testing modality demonstrated in this thesis, provides an indication that 
vestibular	monitoring	may	have	a	role	to	play	in	the	‘wait	and	watch’	presurgical	
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